TWI629282B - Polymerisable compounds and liquid-crystal media - Google Patents

Polymerisable compounds and liquid-crystal media Download PDF

Info

Publication number
TWI629282B
TWI629282B TW099131768A TW99131768A TWI629282B TW I629282 B TWI629282 B TW I629282B TW 099131768 A TW099131768 A TW 099131768A TW 99131768 A TW99131768 A TW 99131768A TW I629282 B TWI629282 B TW I629282B
Authority
TW
Taiwan
Prior art keywords
group
groups
atoms
compound
formula
Prior art date
Application number
TW099131768A
Other languages
Chinese (zh)
Other versions
TW201127847A (en
Inventor
艾西爾 簡森
索斯頓 科狄
哈莫德 函梭
俄達 都瑪姿
Original Assignee
馬克專利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 馬克專利公司 filed Critical 馬克專利公司
Publication of TW201127847A publication Critical patent/TW201127847A/en
Application granted granted Critical
Publication of TWI629282B publication Critical patent/TWI629282B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K19/3405Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a five-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K2019/0444Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group
    • C09K2019/0448Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit characterized by a linking chain between rings or ring systems, a bridging chain between extensive mesogenic moieties or an end chain group the end chain group being a polymerizable end group, e.g. -Sp-P or acrylate
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring
    • C09K2019/3425Six-membered ring with oxygen(s) in fused, bridged or spiro ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本發明係關於式I可聚性化合物The present invention relates to a polymerizable compound of formula I

其中P、Sp、R1、R2、A1、A2、A3、Z1、Z3、V、m、n、o、x及y具有如技術方案1中所指出之含義;且係關於包含至少一種式I化合物之液晶介質。該等化合物較佳為糖衍生物。Wherein P, Sp, R 1 , R 2 , A 1 , A 2 , A 3 , Z 1 , Z 3 , V, m, n, o, x and y have the meanings as indicated in the first embodiment; A liquid crystal medium comprising at least one compound of the formula I. These compounds are preferably sugar derivatives.

Description

可聚性化合物及液晶介質Polymerizable compound and liquid crystal medium

本發明係關於式I可聚性化合物,係關於製備其之方法,係關於其作為液晶介質(LC介質)中組份之用途,且係關於含有此等LC介質之光電顯示元件。該等化合物較佳為糖衍生物。The present invention relates to a polymerizable compound of the formula I, relating to a method for preparing the same, relating to its use as a component in a liquid crystal medium (LC medium), and to a photovoltaic display element containing such an LC medium. These compounds are preferably sugar derivatives.

先前技術揭示在液晶藍相(簡稱為藍相)中作業之顯示元件之介質(WO 04/046805 A1、WO 2008/061606 A1)。The prior art discloses a medium for a display element operating in a liquid crystal blue phase (abbreviated as a blue phase) (WO 04/046805 A1, WO 2008/061606 A1).

藍相通常係在自向列狀態轉變為光學各向同性狀態時觀察到。液晶藍相中之介質可為藍色(如名稱所暗示),亦可為無色。迄今,旨在致力於將藍相之溫度範圍自小於1度擴大至可用於實踐之範圍(參照H. Kikuchi等人,Nature Materials(2002),1(1),64-68;Kikuchi,H.等人,Polymeric Materials Science and Engineering,(2003),89,90-91)。The blue phase is usually observed when transitioning from a nematic state to an optically isotropic state. The medium in the liquid crystal blue phase can be blue (as suggested by the name) or colorless. To date, the aim has been to expand the temperature range of the blue phase from less than 1 degree to practical use (see H. Kikuchi et al., Nature Materials (2002), 1(1), 64-68; Kikuchi, H. Et al, Polymeric Materials Science and Engineering , (2003), 89, 90-91).

WO 2005/080529 A1闡述包含單-及多反應性單體之經聚合物穩定之藍相。WO 2005/080529 A1 describes a polymer-stabilized blue phase comprising mono- and polyreactive monomers.

JP 2005 283 632闡述衍生自碳水化合物之可聚性化合物,其可用於負性記錄材料。其中所述製備方法不能以適用於LC介質之方式製備本發明化合物。該方法不能製造完全官能化之糖衍生物,反之,OH官能基處於打開狀態。其中繪示了結構A及B:JP 2005 283 632 describes polymerizable compounds derived from carbohydrates which can be used for negative recording materials. Wherein the preparation process does not allow the preparation of the compounds of the invention in a manner suitable for use in LC media. This method does not produce a fully functionalized sugar derivative, whereas the OH functional group is in an open state. It shows the structures A and B:

WO1994/014828闡述衍生自所謂的甲基葡糖醇聚醚-20(MG-20,Glucam E-20)之四丙烯酸酯。其係平均具有總計約20個伸乙氧基單元(乙二醇單元)(包括環中之二醇單元)之甲基葡糖苷。因此在形式上,此等材料係具有非一致性組成之烷氧基聚合物。其一般結構大致由下式闡述:WO 1994/014828 describes tetraacrylates derived from the so-called methyl glucitol-20 (MG-20, Glucam E-20). It has an average of about 20 ethoxylated units (ethylene glycol units) (including diol units in the ring) of methyl glucosides. Thus, in form, these materials are alkoxy polymers having a non-uniform composition. Its general structure is roughly described by the following formula:

對於MG-20(Glucam E-20),則參數a、b、c及d之總和為約20,其中a、b、c及d之值可彼此不同。由於此等材料之組成不一致且易發生變化,故自其衍生之可聚性化合物不適於構造可穩定藍相之微調聚合網絡。該等複雜結構使用該等化合物不能達成作為藍相之可複現結果。WO1994/014828之目的在於為(例如)電解槽提供離子導電聚合材料。For MG-20 (Glucam E-20), the sum of the parameters a, b, c and d is about 20, wherein the values of a, b, c and d may differ from each other. Since the composition of these materials is inconsistent and subject to change, the polymerizable compounds derived therefrom are not suitable for constructing a finely tuned polymerization network that stabilizes the blue phase. The use of such compounds by such complex structures does not achieve reproducible results as a blue phase. The purpose of WO 1994/014828 is to provide an ion conducting polymeric material for, for example, an electrolytic cell.

US 5248747及類似公開案(US 5116961)闡述在使用(例如)丙烯酸(酯)、甲基丙烯酸(酯)或丙烯醯胺單體之聚合方法中使用1',6',6'-三甲基丙烯醯基-2,3,3',4,4'-五-O-甲基蔗糖(D)作為交聯劑。US 5,248, 747 and a similar publication (US Pat. No. 5,116,961), the disclosure of which is incorporated herein by reference in its entirety, in the use of the <RTI ID=0.0>0> Propylene fluorenyl-2,3,3',4,4'-penta-O-methylsucrose (D) was used as a crosslinking agent.

化合物D之合成闡述於US 5302676中。在合成過程中,其結構經選擇以使蔗糖之二級羥基官能基呈甲基化形式且一級羥基官能基官能化為甲基丙烯酸酯,該合成總計4步。The synthesis of Compound D is described in US 5,302,676. During the synthesis, the structure is selected such that the secondary hydroxyl functional group of sucrose is methylated and the primary hydroxyl functional group is functionalized to methacrylate. The synthesis is a total of 4 steps.

在實踐中,迄今為止所闡述之經聚合物穩定之藍相使用單反應性非液晶原單體以及二反應性單體(RM257)作為單體。In practice, the polymer stabilized blue phase described so far uses a single reactive non-liquid crystal monomer and a two reactive monomer (RM257) as monomers.

本發明係基於發現可穩定藍相之適宜單體及相應聚合物之目的。該聚合物意欲對經穩定LC相之性質產生以下影響:The present invention is based on the object of finding suitable monomers and corresponding polymers which stabilize the blue phase. The polymer is intended to have the following effects on the properties of the stabilized LC phase:

-加寬藍相溫度範圍,- widen the blue phase temperature range,

-縮短響應時間,- Shorten response time,

-縮小聚合時澄清點(clearing-point)之差異,- reduce the difference in clearing-points during aggregation,

-降低操作電壓(Vop),- lowering the operating voltage (V op ),

-減小操作電壓隨溫度之變化,- reduce the variation of operating voltage with temperature,

-在改變操作電壓時降低槽之透射滯後以達成所界定灰色陰影。- Reduce the transmission hysteresis of the groove when changing the operating voltage to achieve the defined shade of gray.

另外,需要具有良好電壓保持率(VHR)、具有高澄清點且在暴露於光及溫度時穩定之單體材料。此外,為達成在LC主體中之良好分佈,在LC材料中之良好穩定性或與LC材料之良好相容性係必不可少的。In addition, there is a need for a monomer material that has a good voltage holding ratio (VHR), has a high clearing point, and is stable upon exposure to light and temperature. Furthermore, good stability in LC materials or good compatibility with LC materials is essential to achieve a good distribution in the LC body.

具體而言,本發明之目的係提供能夠穩定藍相且適於製備具有改良性質之LC物質的改良之反應性可聚性化合物。In particular, it is an object of the present invention to provide improved reactive polymerizable compounds which are capable of stabilizing the blue phase and are suitable for the preparation of LC materials having improved properties.

此目的係根據本發明藉由通式I化合物達成。This object is achieved according to the invention by a compound of the formula I.

因此,本發明首先係關於式I化合物Therefore, the present invention relates first to compounds of formula I

其中R1及R2 表示Wherein R 1 and R 2 represent

a) 在每一情形下,彼此獨立地,具有1個至15個C原子之鹵代或未經取代之烷基,另外,其中此等基團中之一或多個CH2基團可以O原子彼此不直接連接之方式各自彼此獨立地由-C≡C-、-CH=CH-、-(CO)O-、-O(CO)-、-(CO)-或-O-替代,a) in each case, independently of each other, having from 1 to 15 C atoms of a halogenated or unsubstituted alkyl group, in addition, wherein one or more of the CH 2 groups in such groups may be O The ways in which atoms are not directly connected to each other are each independently replaced by -C≡C-, -CH=CH-, -(CO)O-, -O(CO)-, -(CO)- or -O-,

b) 基團-Sp-P,或b) group-Sp-P, or

c) F、Cl、H、Br、CN、SCN、NCS或SF5,較佳為來自a)或b)之基團,A2 表示A1、A3 各自彼此獨立地表示:c) F, Cl, H, Br, CN, SCN, NCS or SF 5 , preferably a group from a) or b), A 2 represents or A 1 and A 3 are each represented independently of each other:

a) 反-1,4-伸環己基或伸環己烯基,另外,其中一或多個不毗鄰CH2基團可由-O-及/或-S-替代且其中H可經F取代,a) trans-1,4-cyclohexylene or cyclohexenylene, in addition, one or more of the non-adjacent CH 2 groups may be replaced by -O- and/or -S- and wherein H may be substituted by F,

b) 1,4-伸苯基,其中一或兩個CH基團可由N替代且另外,其中一或多個H原子可由Br、Cl、F、CN、甲基、甲氧基或單-或多氟化甲基或甲氧基替代,或b) 1,4-phenylene, wherein one or two CH groups may be replaced by N and additionally, wherein one or more H atoms may be Br, Cl, F, CN, methyl, methoxy or mono- or Polyfluorinated methyl or methoxy substitution, or

c) 來自下列群之基團:二環[1.1.1]戊烷-1,3-二基、二環[2.2.2]辛烷-1,4-二基、螺[3.3]庚烷-2,6-二基、四氫哌喃-2,5-二基、1,3-二噁烷-2,5-二基、四氫呋喃-2,5-二基、環丁-1,3-二基或六氫吡啶-1,4-二基,c) Groups from the following groups: bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane- 2,6-diyl, tetrahydropyran-2,5-diyl, 1,3-dioxane-2,5-diyl, tetrahydrofuran-2,5-diyl, cyclobutane-1,3- Dibasic or hexahydropyridine-1,4-diyl,

其中一或多個氫原子可經F、CN、SCN、SF5、CH2F、CHF2、CF3、OCH2F、OCHF2或OCF3取代,一或多個雙鍵可由單鍵替代,一或多個CH基團可由N替代,M 表示-O-、-S-、-CH2-、-CHY-或-CYY1-,且Y及Y1 表示Cl、F、CN、OCF3或CF3,Z1、Z3 相同或不同且各自彼此獨立地表示單鍵、O、CH2、OC(O)CH2、-CH2O-、-CH2OCH2-、-(CO)O-、-CF2O-、-CH2CH2CF2O-、-CF2CF2-、-CH2CF2-、-CH2CH2-、-(CH2)4-、-CH=CH-、-CH=CF-、-CF=CF-或-C≡C-,其中不對稱橋鍵可向兩側定向,且m 表示0、1、2、3、4、5、6、7或8,較佳為0、1、2、3或4,尤佳為0、1、2或3,n、o 表示0、1、2、3、4或更大,較佳為0、1、2、3或4,尤佳為0、1、2或3,x、y 表示0、1、2、3或4,較佳為0、1或2,其中x+y4,較佳為0、1或2,尤佳為0或1,P 表示可聚性基團,Sp 表示間隔基團或單鍵,-Sp-P 另外亦一起表示基團R1,其中可聚性基團P之數量為一個或更多個。本發明式I化合物不包括公開案JP 2005 283 632中所揭示之糖衍生物AB,不包括甲基葡糖醇聚醚-20四丙烯酸酯(即式C化合物),其中a+b+c+d表示平均20,較佳其中a+b+c+d表示>10之自然數,且不包括如開始時所述之式D化合物。One or more hydrogen atoms may be substituted by F, CN, SCN, SF 5 , CH 2 F, CHF 2 , CF 3 , OCH 2 F, OCHF 2 or OCF 3 , and one or more double bonds may be replaced by a single bond. One or more CH groups may be replaced by N, M represents -O-, -S-, -CH 2 -, -CHY- or -CYY 1 -, and Y and Y 1 represent Cl, F, CN, OCF 3 or CF 3 , Z 1 , Z 3 are the same or different and each independently represents a single bond, O, CH 2 , OC(O)CH 2 , —CH 2 O—, —CH 2 OCH 2 —, —(CO)O -, -CF 2 O-, -CH 2 CH 2 CF 2 O-, -CF 2 CF 2 -, -CH 2 CF 2 -, -CH 2 CH 2 -, -(CH 2 ) 4 -, -CH= CH-, -CH=CF-, -CF=CF- or -C≡C-, wherein the asymmetric bridge can be oriented to both sides, and m represents 0, 1, 2, 3, 4, 5, 6, 7 Or 8, preferably 0, 1, 2, 3 or 4, particularly preferably 0, 1, 2 or 3, n, o means 0, 1, 2, 3, 4 or more, preferably 0, 1 2, 3 or 4, particularly preferably 0, 1, 2 or 3, x, y represents 0, 1, 2, 3 or 4, preferably 0, 1 or 2, wherein x + y 4, preferably 0, 1 or 2, particularly preferably 0 or 1, P represents a polymerizable group, Sp represents a spacer group or a single bond, and -Sp-P additionally represents a group R 1 , wherein The number of the poly groups P is one or more. The compounds of the formula I according to the invention do not include the sugar derivatives A and B disclosed in the publication JP 2005 283 632, excluding methylglycol-20 tetraacrylate (i.e., the compound of formula C ), wherein a+b+ c+d represents an average of 20, preferably wherein a+b+c+d represents a natural number >10 and does not include a compound of formula D as described at the outset.

式I化合物之用途、方法、介質及包含式I化合物之裝置不受此例外影響,即其亦包括結構ABCDThe use, method, medium and apparatus comprising a compound of formula I are not affected by this exception, i.e., they also include structures A , B , C and D.

可聚性基團P係適於聚合反應(例如自由基或離子鏈聚合、加聚或縮聚)或適於聚合物類似物反應(例如加成或縮合至聚合物主鏈上)之基團。尤佳者係用於鏈聚合之基團(具體而言彼等含有C=C雙鍵或-C≡C-三鍵者)、及適於開環聚合之基團(例如,環氧丙烷或環氧基團)。The polymerizable group P is suitable for polymerization (for example, radical or ionic chain polymerization, addition polymerization or polycondensation) or a group suitable for the reaction of a polymer analog (for example, addition or condensation onto the polymer backbone). Particularly preferred are groups for chain polymerization (specifically, those containing a C=C double bond or a -C≡C-triplet), and groups suitable for ring opening polymerization (for example, propylene oxide or Epoxy group).

較佳之基團P選自CH2=CW1-COO-、CH2=CW1-CO-、、CH2=CW2-(O)k3-、CW1=CH-CO-(O)k3-、CW1=CH-CO-NH-、CH2=CW1-CO-NH-、CH3-CH=CH-O-、(CH2=CH)2CH-OCO-、(CH2=CH-CH2)2CH-OCO-、(CH2=CH)2CH-O-、(CH2=CH-CH2)2N-、(CH2=CH-CH2)2N-CO-、HO-CW2W3-、HS-CW2W3-、HW2N-、HO-CW2W3-NH-、CH2=CW1-CO-NH-、CH2=CH-(COO)k1-Phe-(O)k2-、CH2=CH-(CO)k1-Phe-(O)k2-、Phe-CH=CH-、HOOC-、OCN-及W4W5W6Si-,其中W1表示H、F、Cl、CN、CF3、苯基或具有1個至5個C原子之烷基(具體而言H、F、Cl或CH3),W2及W3各自彼此獨立地表示H或具有1個至5個C原子之烷基(具體而言H、甲基、乙基或正丙基),W4、W5及W6各自彼此獨立地表示Cl、具有1個至5個C原子之氧雜烷基或氧雜羰基烷基,W7及W8各自彼此獨立地表示H、Cl或具有1個至5個C原子之烷基,Phe表示1,4-伸苯基(其視情況經一或多個如上文所定義之基團L取代),且k1、k2及k3各自彼此獨立地表示0或1,k3較佳表示1。Preferred groups P are selected from the group consisting of CH 2 =CW 1 -COO-, CH 2 =CW 1 -CO-, , CH 2 =CW 2 -(O) k3 -, CW 1 =CH-CO-(O) k3 -, CW 1 =CH-CO-NH-, CH 2 =CW 1 -CO-NH-,CH 3 - CH=CH-O-, (CH 2 =CH) 2 CH-OCO-, (CH 2 =CH-CH 2 ) 2 CH-OCO-, (CH 2 =CH) 2 CH-O-, (CH 2 = CH-CH 2 ) 2 N-, (CH 2 =CH-CH 2 ) 2 N-CO-, HO-CW 2 W 3 -, HS-CW 2 W 3 -, HW 2 N-, HO-CW 2 W 3 -NH-, CH 2 =CW 1 -CO-NH-,CH 2 =CH-(COO) k1 -Phe-(O) k2 -,CH 2 =CH-(CO) k1 -Phe-(O) k2 -, Phe-CH=CH-, HOOC-, OCN- and W 4 W 5 W 6 Si-, wherein W 1 represents H, F, Cl, CN, CF 3 , phenyl or has 1 to 5 C atoms An alkyl group (specifically H, F, Cl or CH 3 ), each of W 2 and W 3 independently representing H or an alkyl group having 1 to 5 C atoms (specifically H, methyl, B) Or a propyl group, W 4 , W 5 and W 6 each independently represent Cl, an oxaalkyl group having 1 to 5 C atoms or an oxacarbonylalkyl group, and W 7 and W 8 are each independently of each other. H, Cl or an alkyl group having 1 to 5 C atoms, Phe represents a 1,4-phenylene group (which is optionally substituted with one or more groups L as defined above), and k 1 , k 2 and k 3 each independently represent 0 or 1, k 3 Preferably, it is 1.

尤佳之基團P係CH2=CW1-COO-,具體而言CH2=CH-COO-、CH2=C(CH3)-COO-及CH2=CF-COO-,進一步係CH2=CH-O-、(CH2=CH)2CH-OCO-、(CH2=CH)2CH-O-、The preferred group P is CH 2 =CW 1 -COO-, specifically CH 2 =CH-COO-, CH 2 =C(CH 3 )-COO- and CH 2 =CF-COO-, further CH 2 =CH-O-, (CH 2 =CH) 2 CH-OCO-, (CH 2 =CH) 2 CH-O-,

極佳之基團P係乙烯基氧基、丙烯酸酯基、甲基丙烯酸酯基、氟丙烯酸酯基、氯丙烯酸酯基、環氧丙烷基及環氧基,具體而言丙烯酸酯基及甲基丙烯酸酯基。An excellent group P is a vinyloxy group, an acrylate group, a methacrylate group, a fluoroacrylate group, a chloroacrylate group, an oxypropylene group and an epoxy group, specifically an acrylate group and a methyl group. Acrylate based.

端視每分子可聚性基團之數量,本發明單體適於形成不同程度交聯之聚合物。若其僅含有一種可聚性基團,則其形成聚合物鏈。至少在某些情形下,其較佳含有兩個或更多個可聚性基團且用作交聯劑。式I化合物較佳含有2個、3個、4個或5個可聚性基團。其尤佳含有兩個以上可聚性基團,具體而言數量為4個或5個。Depending on the number of polymerizable groups per molecule, the monomers of the invention are suitable for forming polymers which are crosslinked to varying degrees. If it contains only one polymerizable group, it forms a polymer chain. At least in some cases, it preferably contains two or more polymerizable groups and functions as a crosslinking agent. The compounds of formula I preferably contain 2, 3, 4 or 5 polymerizable groups. It is particularly preferred to contain two or more polymerizable groups, specifically 4 or 5.

術語「間隔基團(spacer group,spacer)」上文及下文亦稱為「Sp」,其已為熟習此項技術之人員所習知且闡述於文獻中,參見(例如)Pure Appl. Chem. 73(5),888(2001)及C. Tschierske,G. Pelzl,S. Diele,Angew. Chem. 2004,116,6340-6368。除非另外指出,否則上文及下文術語「間隔基團(spacer group,spacer)」表示在可聚性液晶或液晶原化合物中使液晶原基團與可聚性基團彼此連接之撓性基團。The term "spacer group" is also referred to above and hereinafter as "Sp", which is known to those skilled in the art and is described in the literature, see, for example, Pure Appl. Chem. 73(5), 888 (2001) and C. Tschierske, G. Pelzl, S. Diele, Angew. Chem. 2004, 116, 6340-6368. Unless otherwise indicated, the terms "spacer group" above and below mean a flexible group in which a liquid crystal primary group and a polymerizable group are bonded to each other in a polymerizable liquid crystal or a liquid crystalline raw compound. .

較佳之間隔基團Sp選自式Sp'-X,以使基團P-Sp-符合式P-Sp'-X-,其中Sp'表示具有1個至24個、較佳3個至12個C原子、尤佳4個至12個C原子之伸烷基,其視情況經F、Cl、Br、I或CN單-或多取代,且另外,其中一或多個不毗鄰CH2基團以O及/或S原子彼此不直接連接之方式各自彼此獨立地經-O-、-S-、-NH-、-NR0-、-SiR00R000-、-CO-、-COO-、-OCO-、-OCO-O-、-S-CO-、-CO-S-、-NR00-CO-O-、-O-CO-NR00-、-NR00-CO-NR00-、-CH=CH-或-C≡C-替代,其中一個或沒有CH2基團被替代較佳,X 表示-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR00-、-NR00-CO-、-NR00-CO-NR00-、-OCH2-、-CH2O-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CF2CH2-、-CH2CF2-、-CF2CF2-、-CH=N-、-N=CH-、-N=N-、-CH=CR0-、-CY2=CY3-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-或單鍵,較佳為單鍵、-O-、-OCO-或-OCH2-,R00及R000各自彼此獨立地表示H或具有1個至12個C原子之烷基,且Y2及Y3各自彼此獨立地表示H、F、Cl或CN。Preferably, the spacer group Sp is selected from the group of Sp'-X such that the group P-Sp- conforms to the formula P-Sp'-X-, wherein Sp' represents from 1 to 24, preferably from 3 to 12 a C atom, particularly preferably an alkyl group of 4 to 12 C atoms, which is optionally mono- or polysubstituted by F, Cl, Br, I or CN, and additionally, one or more of which are not adjacent to the CH 2 group Each of O and/or S atoms are independently connected to each other by -O-, -S-, -NH-, -NR 0 -, -SiR 00 R 000 -, -CO-, -COO-, -OCO-, -OCO-O-, -S-CO-, -CO-S-, -NR 00 -CO-O-, -O-CO-NR 00 -, -NR 00 -CO-NR 00 -, -CH=CH- or -C≡C-substitution, wherein one or none of the CH 2 groups are substituted, X represents -O-, -S-, -CO-, -COO-, -OCO-, -O -COO-, -CO-NR 00 -, -NR 00 -CO-, -NR 00 -CO-NR 00 -, -OCH 2 -, -CH 2 O-, -SCH 2 -, -CH 2 S-, -CF 2 O-, -OCF 2 -, -CF 2 S-, -SCF 2 -, -CF 2 CH 2 -, -CH 2 CF 2 -, -CF 2 CF 2 -, -CH=N-, - N=CH-, -N=N-, -CH=CR 0 -, -CY 2 =CY 3 -, -C≡C-, -CH=CH-COO-, -OCO-CH=CH- or single bond , preferably a single bond, -O -, - OCO- or -OCH 2 -, R 00 and R 000 are each independently represents H or alkyl having 1-12 C atoms, and Y 2 and Y 3 each independently represents H, F, Cl or CN another.

X較佳為-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR0-、-NR0-CO-、-NR0-CO-NR0-或單鍵。X is preferably -O-, -S-, -CO-, -COO-, -OCO-, -O-COO-, -CO-NR 0 -, -NR 0 -CO-, -NR 0 -CO- NR 0 - or single button.

典型間隔基團Sp'係(例如)-(CH2)p1-、-(CH2CH2O)p2、-CH2CH2-、-CH2CH2-S-CH2CH2-、-CH2CH2-NH-CH2CH2-或-(SiR00R000-O)p1-,其中p1係1至24之整數,較佳3,p2係1至6之整數,且R00及R000具有上文所指出之含義。A typical spacer group Sp' is, for example, -(CH 2 ) p1 -, -(CH 2 CH 2 O) p2 , -CH 2 CH 2 -, -CH 2 CH 2 -S-CH 2 CH 2 -, - CH 2 CH 2 -NH-CH 2 CH 2 - or -(SiR 00 R 000 -O) p1 -, wherein p1 is an integer from 1 to 24, preferably 3, p2 is an integer from 1 to 6, and R 00 and R 000 have the meanings indicated above.

尤佳之基團-X-Sp'-係-(CH2)p1-、-O-(CH2)p1-、-OCO-(CH2)p1-、-OCOO-(CH2)p1-,其中p1係如上文所定義。The preferred group -X-Sp'-system -(CH 2 ) p1 -, -O-(CH 2 ) p1 -, -OCO-(CH 2 ) p1 -, -OCOO-(CH 2 ) p1 -, Wherein p1 is as defined above.

在每一情形下,尤佳之基團Sp'係(例如)直鏈伸乙基、伸丙基、伸丁基、伸戊基、伸己基、伸庚基、伸辛基、伸壬基、伸癸基、伸十一烷基、伸十二烷基、伸十八烷基、伸乙基氧基伸乙基、亞甲基氧基伸丁基、伸乙基硫基伸乙基、伸乙基-N-甲基亞胺基伸乙基、1-甲基伸烷基、伸乙烯基、伸丙烯基及伸丁烯基。Sp'尤佳為如上文所定義之伸烷基,其在基團X代表單鍵之情形下具有4個至12個C原子或在基團X不代表單鍵之情形下具有3個至12個C原子。In each case, the preferred group Sp' is, for example, a straight-chain ethyl group, a propyl group, a butyl group, a pentyl group, a hexyl group, a heptyl group, a decyl group, a decyl group, Stretching, stretching, undecyl, dodecyl, octadecyl, ethyl ethoxy, methyl, methyleneoxy, butyl, ethylthio, ethyl, ethyl N-methylimido group exoethyl, 1-methylalkylene, vinyl, propylene and butylene. Sp' is particularly preferably an alkylene group as defined above having 4 to 12 C atoms in the case where the group X represents a single bond or 3 to 12 in the case where the group X does not represent a single bond C atoms.

A1及A3若出現一次以上(對於x或y>1而言),則其可採用不同含義。此同樣適用於基團Z1、Z3及-Sp-P。基團-Sp-P較佳彼此相同。If A 1 and A 3 occur more than once (for x or y > 1), they can have different meanings. The same applies to the groups Z 1 , Z 3 and -Sp-P. The groups -Sp-P are preferably identical to each other.

基團R1及R2較佳彼此獨立地表示基團P-Sp-、H、具有1-10個C原子之烷基、烷氧基或烷氧基甲基。The groups R 1 and R 2 preferably independently of each other represent a group P-Sp-, H, an alkyl group having 1 to 10 C atoms, an alkoxy group or an alkoxymethyl group.

本發明化合物尤其適合作為液晶介質中之可聚性組份。該聚合物在各個方面均滿足出於使液晶相(具體而言藍相)穩定之目的所做出的要求。與習用系統相比,觀察到操作電壓顯著減小。同時,減小形成透射滯後之趨勢(灰值),該滯後取決於(增加或減小)操作電壓。另外,對於PSA-VA型顯示器(參照JP 10-036847 A、EP 1170626 A2、US 6861107、US 7169449、US 2004/0191428、US 2006/0066793)及其他PSA(「聚合物穩定配向」)顯示器而言,混合物中作為可聚性組份之化合物的量<1%係合適的。另外,在許多情形下其可簡單地自市售糖化合物來製備。The compounds of the invention are especially suitable as a polymerizable component in liquid crystal media. The polymer satisfies in every respect the requirements for the purpose of stabilizing the liquid crystal phase, in particular the blue phase. A significant reduction in operating voltage was observed compared to conventional systems. At the same time, the tendency to form a transmission hysteresis (gray value) is reduced, which depends on (increasing or decreasing) the operating voltage. In addition, for PSA-VA type displays (refer to JP 10-036847 A, EP 1170626 A2, US 6861107, US 7169449, US 2004/0191428, US 2006/0066793) and other PSA ("Polymer Stabilized Alignment") displays. The amount of the compound which is a polymerizable component in the mixture is preferably <1%. Additionally, in many cases it can be prepared simply from commercially available sugar compounds.

尤佳之式I化合物係衍生自碳水化合物或亦稱為糖之物質。術語碳水化合物及糖已為熟習此項技術者所熟悉。其係多元醇氧化之產物,即羥基醛(醛糖)或羥基酮(酮糖)及自其衍生之化合物及其縮合物。A particularly preferred compound of formula I is derived from a carbohydrate or a substance also known as a sugar. The terms carbohydrate and sugar are well known to those skilled in the art. It is a product of oxidation of a polyol, that is, a hydroxy aldehyde (aldose) or a hydroxy ketone (ketose) and a compound derived therefrom and a condensate thereof.

尤佳之I型化合物衍生自具有五個(戊糖,例如木糖)或六個碳原子(己糖類,例如葡萄糖)之單糖(簡單糖)。其能夠發生環閉合。此反應之平衡通常處於環狀半縮醛之一側。在溶液或固體中開鏈形式通常忽略不計。此處,糖可呈呋喃糖(5-員環)或哌喃糖(6-員環)形式。此外,在環閉合時形成新的立體中心。可端視OH基團之位置對α及β端基異構體進行區分。A preferred type I compound is derived from a monosaccharide (simple sugar) having five (pentose sugars such as xylose) or six carbon atoms (hexoses such as glucose). It is capable of ring closure. The equilibrium of this reaction is usually on one side of the cyclic hemiacetal. The open-chain form in solution or solid is usually negligible. Here, the sugar may be in the form of a furanose (5-membered ring) or a pumose (6-membered ring). In addition, a new solid center is formed when the ring is closed. The alpha and beta anomers can be distinguished by looking at the position of the OH group.

舉例而言,葡萄糖之對映異構形式係由前綴D及L表示。事實上,排他性地存在D-葡萄糖。L-葡萄糖僅能以合成方式獲得。For example, the enantiomeric forms of glucose are represented by the prefixes D and L. In fact, D-glucose is exclusively present. L-glucose can only be obtained synthetically.

只有糖的主要存在形式才由下文其名稱表示。舉例而言,D-葡萄糖實際上排他性地以哌喃糖形式存在。下文D-葡萄糖因此表示為:Only the main form of sugar is represented by its name below. For example, D-glucose is actually exclusively present in the form of a pumose. The following D-glucose is therefore expressed as:

端基異構中心處之波浪狀楔形鍵指示其為或可能為α及β端基異構體之混合物。有關單糖之詳細資料參見[Monosaccharides: Their Chemistry and their roles in natural products. P. Collins及R. Ferrier 1995 John Wiley & Sons,Chichester.]。The wavy wedge bond at the anomeric center indicates that it is or may be a mixture of alpha and beta anomers. For more information on monosaccharides see [ Mongosaccharides : Their Chemistry and their roles in natural products . P. Collins and R. Ferrier 1995 John Wiley & Sons , Chichester.].

本發明尤佳之化合物衍生自(例如)下列糖:Particularly preferred compounds of the invention are derived from, for example, the following sugars:

用於合成本發明化合物I之較佳起始材料之選擇並非僅限於天然存在之碳水化合物。可以合成方式獲得之糖、對映異構體、衍生物或經化學反應修飾之化合物亦為本發明式I化合物之較佳起始材料。因此,在廣泛意義上,多羥基哌喃及多羥基呋喃係本發明化合物I之較佳起始材料。The preferred starting materials for the synthesis of Compound I of the present invention are not limited to naturally occurring carbohydrates. The sugars, enantiomers, derivatives or chemically modified compounds which can be obtained synthetically are also preferred starting materials for the compounds of the formula I according to the invention. Thus, in a broad sense, polyhydroxypyran and polyhydroxyfuran are preferred starting materials for the compound I of the invention.

在本發明之較佳實施例中,x及y二者均表示0,如式IA中所示:In a preferred embodiment of the invention, both x and y represent zero, as shown in formula IA:

其中R1、R2、Sp、P、m及A2係如上文所定義。Wherein R 1 , R 2 , Sp, P, m and A 2 are as defined above.

上文及下文基團[P-Sp-]可處於任一所存在H原子位置,即,亦可直接毗鄰R1或R2The above and below groups [P-Sp-] may be in the position of any H atom present, that is, directly adjacent to R 1 or R 2 .

尤佳之式IA結構示於下文子式IA-1至IA-32中,其中選擇平面表示法。因此包括所有可能之立體異構體(對映異構體及非對映異構體,參照上文糖結構)。出於本發明之目的,較佳者為由上文所揭示糖結構產生之所有可能之立體異構體。此等可呈立體異構純淨形式或呈立體異構體混合物形式。A preferred embodiment of the IA structure is shown in sub-forms IA-1 through IA-32 below, in which a planar representation is selected. All possible stereoisomers (enantiomers and diastereomers, reference to the above sugar structure) are therefore included. For the purposes of the present invention, all possible stereoisomers resulting from the sugar structures disclosed above are preferred. These may be in stereoisomeric pure form or in the form of a mixture of stereoisomers.

其中R1'至R5'採用針對R1所指出之含義,但R1'-5'較佳為氫、具有1個至12個C原子之直鏈或具直鏈烷基、烯基、烷氧基或烷氧基甲基,尤佳為氫或烷氧基,且其中X1至X5係如上文X所定義,Sp1至Sp5係如上文Sp'所定義,且P1至P5係如上文P所定義。Wherein R 1 ' to R 5 ' have the meanings indicated for R 1 , but R 1 '-5' is preferably hydrogen, a straight or linear alkyl group having 1 to 12 C atoms, an alkenyl group, Alkoxy or alkoxymethyl, more preferably hydrogen or alkoxy, and wherein X 1 to X 5 are as defined above for X, and Sp 1 to Sp 5 are as defined above for Sp', and P 1 to P 5 is as defined in P above.

其中,含有四氫哌喃環之化合物(IA1-IA19)尤佳。其中,彼等含有兩個以上可聚性基團者較佳(IA1-IA10)。Among them, a compound containing a tetrahydropyran ring (IA1-IA19) is particularly preferable. Among them, those having more than two polymerizable groups are preferred (IA1-IA10).

在本發明之又一較佳實施例中,x+y>0。此處,來自式I之多官能化環A2尤佳經下式之液晶原基團取代:In still another preferred embodiment of the invention, x+y>0. Here, the polyfunctionalized ring A 2 from formula I is preferably substituted by a liquid crystal original group of the formula:

此處,基團較佳採用下列含義:Here, the group preferably has the following meanings:

其中Z4採用Z1/Z3含義中之一者。Wherein Z 4 is one of the meanings of Z 1 /Z 3 .

上文及下文子式之基團Above and below Group

較佳表示選自下列子式之基團:Preferably, it represents a group selected from the group consisting of:

液晶原基團較佳經由橋鍵連接至(多)羥基哌喃單元。由於特殊反應性,此處尤佳經由己糖之CH2OH官能基及/或經由端基異構中心上之OH官能基進行連接。此處以葡萄糖為例對此等位置進行標記:The liquid crystal primordial group is preferably attached to the (poly)hydroxypiperan unit via a bridge. Due to the particular reactivity, it is preferred here to carry out the attachment via the CH 2 OH functional group of the hexose and/or via the OH functional group on the terminal isomerization center. Here, glucose is used as an example to mark these locations:

尤佳之橋鍵Z1、Z3係(例如)單鍵、尤佳的桥键 Z 1 , Z 3 series (for example) single bond,

and

尤佳地,參數x或y中一者等於0。自其得到之較佳結構IB下文以子式IB-1至IB-5示出,其中選擇平面表示法。因此包括所有可能之立體異構體(對映異構體及非對映異構體,參照上文糖結構)。出於本發明之目的,較佳者為由上文所揭示糖結構產生之所有可能之立體異構體。此等可呈立體異構純淨形式或呈立體異構體混合物形式。More preferably, one of the parameters x or y is equal to zero. The preferred structure IB obtained therefrom is shown below in sub-forms IB-1 to IB-5, wherein a planar representation is selected. All possible stereoisomers (enantiomers and diastereomers, reference to the above sugar structure) are therefore included. For the purposes of the present invention, all possible stereoisomers resulting from the sugar structures disclosed above are preferred. These may be in stereoisomeric pure form or in the form of a mixture of stereoisomers.

此外,式IB中之Sp1-5-P1-5可一或多次由R1'-5'替代。此較佳適於P5-Sp5-及/或P1-Sp1-。此處,R1'-5'採用針對R1所給出之含義,但R1'-5'較佳為氫、具有1個至12個C原子之直鏈或具直鏈烷基、烯基、烷氧基或烷氧基甲基,尤佳為氫或烷氧基。Further, Sp 1-5 -P 1-5 in Formula IB may be replaced by R 1 '-5' one or more times. This is preferably suitable for P 5 -Sp 5 - and/or P 1 -Sp 1 -. Here, R 1 '-5' has the meaning given for R 1 , but R 1 '-5' is preferably hydrogen, a straight or linear alkyl group having 1 to 12 C atoms, alkene Alkyl, alkoxy or alkoxymethyl, more preferably hydrogen or alkoxy.

其中R1、A1、Z1、X1-5、Sp1-5、P1-5及x係如上文所指出來定義。Wherein R 1 , A 1 , Z 1 , X 1-5 , Sp 1-5 , P 1-5 and x are as defined above.

尤佳者係IB-1型及IB-5型化合物。Especially preferred are IB-1 and IB-5 compounds.

尤佳之結構I(其中x及y二者均不為0)下文以子式IC-1至IC-3示出。此處選擇平面表示法。然而,出於本發明之目的,較佳者為由環上取代基位置產生之所有可能之立體異構體(對映異構體及非對映異構體)。此等可呈立體異構純淨形式或呈立體異構體混合物形式。此外,式IC中之Sp1-5-P1-5可一或多次由R1'-5'替代。此較佳適於P5-Sp5-及/或P1-Sp1-。此處,R1'-5'採用針對R1,2所給出之含義,但R1'-5'較佳為氫、具有1個至12個C原子之直鏈或具直鏈烷基、烯基、烷氧基或烷氧基甲基,尤佳為氫或烷氧基。A particularly preferred structure I (wherein both x and y are not zero) is shown below in sub-forms IC-1 to IC-3. Select the plane representation here. For the purposes of the present invention, however, all possible stereoisomers (enantiomers and diastereomers) which result from the position of the substituent on the ring are preferred. These may be in stereoisomeric pure form or in the form of a mixture of stereoisomers. Further, Sp 1-5 -P 1-5 in the formula IC may be replaced by R 1 '-5' one or more times. This is preferably suitable for P 5 -Sp 5 - and/or P 1 -Sp 1 -. Here, R 1 '-5' has the meaning given for R 1,2 , but R 1 '-5' is preferably hydrogen, a straight or linear alkyl group having 1 to 12 C atoms. Alkenyl, alkoxy or alkoxymethyl, more preferably hydrogen or alkoxy.

其中R1、R2、A1、A2、Z1、Z2、X1-5、Sp1-5、P1-5、x及y係如上文所指出來定義。Wherein R 1 , R 2 , A 1 , A 2 , Z 1 , Z 2 , X 1-5 , Sp 1-5 , P 1-5 , x and y are as defined above.

極佳者係IC-1型化合物。An excellent compound is an IC-1 type compound.

可經由糖苷鍵藉由縮合反應將簡單糖連接在一起,得到雙糖或多糖。Simple sugars can be linked together via a glycosidic bond by a condensation reaction to give a disaccharide or polysaccharide.

較佳之式I化合物亦衍生自二糖(雙糖,例如冰糖或乳糖)。Preferred compounds of formula I are also derived from disaccharides (disaccharides such as rock sugar or lactose).

本發明之尤佳化合物係衍生自(例如)麥芽糖、纖維二糖、異麥芽糖、異麥芽酮糖、龍膽二糖、海藻糖、蔗糖、乳糖、昆布二糖。Particularly preferred compounds of the invention are derived, for example, from maltose, cellobiose, isomaltose, isomaltulose, gentiobiose, trehalose, sucrose, lactose, lauryl disaccharide.

用於合成本發明化合物I之較佳二糖之選擇並不限於天然存在之化合物。以合成方式獲得之對映異構體、衍生物或經化學反應修飾之化合物亦為本發明式I化合物之較佳起始材料。The choice of preferred disaccharides for the synthesis of Compound I of the present invention is not limited to naturally occurring compounds. Syntheticly obtained enantiomers, derivatives or chemically modified compounds are also preferred starting materials for the compounds of formula I of the invention.

衍生自麥芽糖之尤佳化合物之子式。A subtype of a particularly good compound derived from maltose.

衍生自蔗糖之尤佳化合物之子式。A subform of a particularly preferred compound derived from sucrose.

所選合成方法係借助實例自尤佳之單糖開始進行闡述。特定而言,合成方法係借助實例參照D-(+)-木糖(1)、L-(+)-阿拉伯糖(35)、脫氧-D-核糖(16)、D-(+)-葡萄糖(70)及D-(+)-半乳糖(116)進行闡述。此等意欲說明(而非限制)本發明。熟習此項技術之人員將能夠容易地將所述方法應用至其他起始材料。The selected synthetic method is illustrated by an example starting from the preferred monosaccharide. In particular, the synthetic method refers to D-(+)-xylose (1) , L-(+)-arabinose (35) , deoxy-D-ribose (16) , D-(+)-glucose by way of example. (70) and D-(+)-galactose (116) are described. These are intended to illustrate, not limit, the invention. Those skilled in the art will be able to readily apply the method to other starting materials.

此外,具體而言,此處將對含有尤佳丙烯酸酯型可聚性基團之I型化合物予以論述,其中可聚性基團P通常表示CH2=CW1-COO-,其中W1係如上文針對式I所定義。此等極佳包括丙烯酸酯基(CH2=CH-COO-)及甲基丙烯酸酯基(CH2=C(CH3)-COO-)。Further, in particular, a type I compound containing a particularly preferred acrylate type polymerizable group will be discussed herein, wherein the polymerizable group P generally represents CH 2 =CW 1 -COO-, wherein the W 1 system As defined above for Formula I. These excellent include acrylate groups (CH 2 =CH-COO-) and methacrylate groups (CH 2 =C(CH 3 )-COO-).

碳水化合物之羥基官能基對於建構間隔基團而言至關重要,此意味著預先指定-O-作為間隔基團-Sp'-X-之一部分。該等化合物尤佳。The hydroxy functional group of the carbohydrate is critical for the construction of the spacer group, which means that -O- is pre-specified as part of the spacer group -Sp'-X-. These compounds are especially preferred.

在尤佳方法中,使用ω-溴鏈烷酸2藉由酯化來建構間隔基團Sp'-X(其等於-OC(O)-(CH2)p1-)。此處及下文位標ω意指取代基(此處為溴)位於鏈末端,如(例如)在5-溴戊酸(5-bromovaleric acid)=5-溴戊酸(5-bromopentanoic acid)中。然後可藉由與丙烯酸4(R=H或Me較佳)反應將所得化合物3轉化為I型可聚性化合物(例如反應圖1中之化合物5)。In a preferred method, the spacer group Sp'-X (which is equal to -OC(O)-(CH 2 ) p1 -) is constructed by esterification using ω-bromoalkanoic acid 2 . Here and below the position ω means that the substituent (here bromine) is at the end of the chain, such as, for example, in 5-bromovaleric acid = 5-bromopentanoic acid . The resulting compound 3 can then be converted to a type I polymerizable compound by reaction with acrylic acid 4 (R = H or Me is preferred) (e.g., compound 5 in reaction Figure 1 ).

反應圖1:Sp=-O-C(O)-(CHReaction Figure 1: Sp=-O-C(O)-(CH 22 )) p1P1 -之化合物I(尤其=5)之合成,以D-(+)-木糖(1)為例。在此圖式中,W- Synthesis of Compound I (especially = 5), taking D-(+)-xylose (1) as an example. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

對於中間體3之合成,亦能使用ω-溴烷醯基氯6。此等化合物可自羧酸2(例如)藉由與亞硫醯氯反應來獲得。For the synthesis of intermediate 3 , ω-bromoalkylphosphonium chloride 6 can also be used. Such compounds can be obtained from carboxylic acid 2 , for example by reaction with sulfinium chloride.

反應圖2:使用ω-溴烷醯基氯6來合成中間體3Reaction Figure 2: Synthesis of Intermediate 3 using ω-bromoalkylphosphonium chloride 6

其他較佳之化合物係彼等其中Sp'-X=-O-(CH2)p1-者,其中參數p1較佳大於2。Other preferred compounds are those in which Sp'-X=-O-(CH 2 ) p1 - wherein the parameter p1 is preferably greater than 2.

獲得尤佳化合物(其中p1=3)之方法示於反應圖3中,仍然以D-(+)-木糖(1)之反應為例。A method for obtaining a particularly preferred compound (where p1 = 3) is shown in Reaction Scheme 3 , and still taking the reaction of D-(+)-xylose (1) as an example.

反應圖3:Sp=-O-(CHReaction Figure 3: Sp=-O-(CH 22 )) 33 -之化合物I(尤其=11)之合成,以D-(+)-木糖(1)之反應為例。在此圖式中,W- Synthesis of Compound I (especially = 11), taking the reaction of D-(+)-xylose (1) as an example. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

首先,使用烯丙基溴(7)對糖1實施烷基化/烯丙基化[A. Leydet等人,J. Med. Chem. 1997,40,350-356]。烯丙基溴(7)係足夠強之烷基化試劑,其亦可使二級醇官能基有效且完全烷基化。其他烷基化試劑(例如,烷基溴化物或甲苯磺酸烷基酯)通常不具有足夠的反應性而不能與游離糖充分反應。First, alkylation/allylation of sugar 1 is carried out using allyl bromide (7) [A. Leydet et al., J. Med . Chem . 1997 , 40, 350-356]. Allyl bromide (7) is a sufficiently strong alkylating agent which also allows efficient and complete alkylation of the secondary alcohol functionality. Other alkylating agents (e.g., alkyl bromides or alkyl tosylates) generally do not have sufficient reactivity to adequately react with the free sugars.

然後實施硼氫化/氧化反應以構建1,3-丙二醇間隔基團,得到化合物9。然後使用丙烯醯氯或丙烯酸對化合物9實施酯化(方法A)或(方法B),得到化合物11。出於本發明之目的,其他較佳起始材料可以類似方式實施此反應順序。A hydroboration/oxidation reaction is then carried out to construct a 1,3-propanediol spacer group to give compound 9 . Compound 9 is then esterified (Method A) or (Method B) using acrylonitrile or acrylic acid to provide compound 11 . For the purposes of the present invention, other preferred starting materials can be carried out in a similar manner.

全烯丙基化化合物8或類似物亦係用於獲得含有乙二醇間隔基團(Sp'-X'=O(CH2)2-)之化合物的適宜起始材料。為此,藉助臭氧分解使雙鍵斷裂,並將所得醛12還原成13。然而,為獲得製備上可接受之產率,似乎直接使用氧化鋁上之硼氫化鈉將在臭氧分解(未顯示)初期所形成的臭氧化物還原成醇13更為有利[M. Dubber,T. Lindhorst,Carbohydr. Res. 1998,310,35-41]。Allally propylated compound8Or an analog is also used to obtain a glycol-containing spacer group (Sp'-X'=O(CH)2)2A suitable starting material for the compound of -). For this purpose, the double bond is cleaved by means of ozonolysis and the resulting aldehyde is obtained.12Restore to13. However, in order to obtain a production-acceptable yield, it seems that the ozonide formed in the initial stage of ozonolysis (not shown) is directly reduced to an alcohol using sodium borohydride on alumina.13More favorable [M. Dubber, T. Lindhorst,Carbohydr.Res. 1998, 310, 35-41].

反應圖4:Sp=-O-(CHReaction Figure 4: Sp=-O-(CH 22 )) 22 -之化合物I(尤其=14)之合成,以D-(+)-木糖(1)之反應為例。在此圖式中,W- Synthesis of Compound I (especially = 14), taking the reaction of D-(+)-xylose (1) as an example. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

亦可將1,n-二醇間隔基團之游離OH基團轉化為相應溴化物15。該等化合物同樣係用於合成化合物I之有價值的中間體。The free OH group of the 1,n-diol spacer group can also be converted to the corresponding bromide 15 . These compounds are also useful as intermediates for the synthesis of Compound I.

反應圖5:作為化合物I之合成中間體之烷基溴化物15之合成。自D-(+)-木糖(1)獲得之物質之合成實例。Reaction Scheme 5: Synthesis of alkyl bromide 15 as a synthetic intermediate of Compound I. An example of the synthesis of a material obtained from D-(+)-xylose (1).

15之烷基溴化物或類似化合物(參照反應圖6,脫氧-D-核糖(16)之反應實例)可與含碳親核試劑(例如18型烷基-格氏試劑)反應,得到其中Sp'-X=-O-(CH2)3(CH2)p1-之化合物。此示於反應圖6中,以2-脫氧-D-核糖(16)之反應為例。溴化物17之合成係如上文所述實施。然後使1718型烷基-格氏試劑(PG=保護基團)反應。去除醇保護基團,得到醇20。然後可使羥基官能基與丙烯酸(衍生物)反應,得到化合物21An alkyl bromide of the formula 15 or a similar compound (refer to the reaction scheme of Figure 6 , a reaction example of deoxy-D-ribose ( 16 )) can be reacted with a carbon-containing nucleophile (for example, an 18-type alkyl-Grignard reagent) to obtain A compound of Sp'-X=-O-(CH 2 ) 3 (CH 2 ) p1 -. This is shown in Reaction Scheme 6 , taking the reaction of 2-deoxy-D-ribose ( 16 ) as an example. The synthesis of bromide 17 was carried out as described above. The 17 and 18 type alkyl-Grignard reagents (PG = protecting group) are then reacted. Removal of the alcohol protecting group provides the alcohol 20 . The hydroxy functional group can then be reacted with an acrylic acid (derivative) to give compound 21 .

反應圖6:Sp=-O-(CHReaction Figure 6: Sp=-O-(CH 22 )) 33 (CH(CH 22 )) p1P1 -之化合物I(尤其=21)之合成,以2-脫氧-D-核糖(16)之反應為例。在此圖式中,W- Synthesis of Compound I (especially = 21), taking the reaction of 2-deoxy-D-ribose (16) as an example. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

當然亦可將化合物(例如化合物9)之OH基團轉化為其他適宜離去基團。除溴化物外,尤佳者亦係碘化物、氯化物、甲苯磺酸酯、甲磺酸酯或三氟甲磺酸酯(在每一情形下均未顯示)。It is of course also possible to convert the OH group of the compound (for example compound 9 ) to another suitable leaving group. In addition to bromide, it is especially preferred to be iodide, chloride, tosylate, mesylate or triflate (not shown in each case).

O-烯丙基化化合物之臭氧分解所獲得之受質(參照反應圖4反應圖7)適於在(例如)與24型試劑(PG=保護基團,較佳為甲矽烷基保護基團)之Wittig反應中產生含有烯基間隔基團之化合物(例如反應圖727)。The substrate obtained by ozonolysis of the O-allylation compound (refer to Reaction Scheme 4 or Reaction Scheme 7 ) is suitable, for example, with a type 24 reagent (PG = protecting group, preferably a germyl protecting group) The Wittig reaction of the group) produces a compound containing an alkenyl spacer group (for example, 27 in the reaction scheme 7 ).

反應圖7:Sp=-O-(CHReaction Figure 7: Sp=-O-(CH 22 )C=C-(CH)C=C-(CH) 22 )) p1P1 -之化合物I(尤其=27)之合成,以2-脫氧-D-核糖(16)之反應為例。在此圖式中,W- Synthesis of Compound I (especially = 27), taking the reaction of 2-deoxy-D-ribose (16) as an example. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

若含有烷基間隔基團之化合物係自醛(例如23)製得,則28型Wittig試劑尤其適宜。對Wittig反應之產物實施氫化,在此期間苄基保護基團解離且雙鍵被氫化。此方法列示於反應圖8中。The 28 type Wittig reagent is especially suitable if the compound containing an alkyl spacer group is prepared from an aldehyde (e.g., 23 ). The product of the Wittig reaction is subjected to hydrogenation, during which the benzyl protecting group dissociates and the double bond is hydrogenated. This method is listed in Reaction Scheme 8 .

反應圖8:Sp=-O-(CHReaction Figure 8: Sp=-O-(CH 22 )) 33 (CH(CH 22 )) p1P1 -之化合物I(尤其=21)之合成,以2-脫氧-D-核糖(16)之反應為例。在此圖式中,W- Synthesis of Compound I (especially = 21), taking the reaction of 2-deoxy-D-ribose (16) as an example. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

一般而言,中間體(例如2026)之合成不一定需要使用保護基團。亦能使用[HO-(CH2)p1-CH2PPh3]+Br-型Wittig試劑(未顯示)。用於合成Sp=-(CH2)-C=C-(CH2)p1-或Sp=-(CH2)3(CH2)p1-之化合物I之其他較佳試劑係溴烷基-Wittig鹽30。醛(例如12)之Wittig反應得到化合物31,然後可(例如)在鹼存在下使用丙烯酸6將其轉化為其中Sp=-(CH2)-C=C-(CH2)p1-之化合物I(參照反應圖9中之實例32)。In general, the synthesis of intermediates (e.g., 20 and 26 ) does not necessarily require the use of a protecting group. [HO-(CH 2 ) p1 -CH 2 PPh 3 ] + Br - type Wittig reagent (not shown) can also be used. Other preferred reagents for the synthesis of Compound I of Sp = -(CH 2 )-C=C-(CH 2 ) p1 - or Sp = -(CH 2 ) 3 (CH 2 ) p1 - are bromoalkyl-Wittig Salt 30 . The Wittig reaction of an aldehyde (e.g., 12 ) gives compound 31 which can then be converted, for example, to the compound I wherein Sp = -(CH 2 )-C = C-(CH 2 ) p1 - using the acrylic acid 6 in the presence of a base. (Refer to Example 32 in Reaction Scheme 9 ).

反應圖9:Sp=-(CHReaction Figure 9: Sp=-(CH 22 )-C=C-(CH)-C=C-(CH 22 )) p1P1 -之化合物I(尤其=32)之合成,以使用溴烷基-Wittig鹽30之醛12之反應為例。在此圖式中,WThe synthesis of the compound I (especially = 32) is exemplified by the reaction using the aldehyde 12 of the bromoalkyl-Wittig salt 30. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

為以此方式獲得Sp=-(CH2)3(CH2)p1-之化合物I(參照反應圖10中化合物34),對中間體31實施氫化。隨後使所得化合物33與丙烯酸4反應。To obtain Compound I of Sp = -(CH 2 ) 3 (CH 2 ) p1 - in this manner (refer to Compound 34 in Reaction Scheme 10 ), Intermediate 31 was subjected to hydrogenation. The resulting compound 33 was then reacted with acrylic acid 4 .

反應圖10:自中間體31合成Sp=-(CHReaction Scheme 10: Synthesis of Sp=-(CH from Intermediate 31) 22 )) 33 (CH(CH 22 )) p1P1 -之化合物I。在此圖式中,W- Compound I. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

一般而言,使用受保護之溴代烷醇36(或碘化物、甲苯磺酸酯或三氟甲磺酸酯)之游離糖烷基化反應亦適於合成含有HO-(CH2)p1-OH基團之尤佳間隔基團(參照反應圖11)。In general, the free sugar alkylation reaction using a protected bromoalkanol 36 (or iodide, tosylate or triflate) is also suitable for the synthesis of HO-(CH 2 ) p1 - A particularly preferred spacer group for the OH group (see Figure 11 for the reaction ).

反應圖11:Sp=-O-(CHReaction Figure 11: Sp=-O-(CH 22 )) p1P1 -之化合物I(尤其=39)之合成,以L-(+)-阿拉伯糖(35)之反應為例。在此圖式中,W- Synthesis of Compound I (especially = 39), taking the reaction of L-(+)-arabinose (35) as an example. In this figure, W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

然而,此烷基化形式通常並不不適於(具體而言)使碳水化合物之二級OH基團充分烷基化。此外,困難程度隨欲烷基化之二級OH基團之數量而增加。對於某些應用而言,例如先前技術(JP 2005 283 632)中所闡述4,6-O-亞乙基-α-D-哌喃葡萄糖之烷基化反應,獲得不同烷基化結構單元之混合物即已足夠。然而,對於此處針對LC顯示器應用所述之應用而言,需要能夠製備高純度之單獨化合物以製備明確定義之混合物。上文所述方法似乎不適於此目的。具體而言,在常用於有機反應之反應介質(溶劑,例如二氯甲烷、醚、乙酸乙酯、甲苯等)中,「游離」糖中存在之多個OH基團通常會妨礙進行充分合成處理之能力。因此,糖化學中之一種方法係首先實施保護,在許多情形下甚至首先對所有OH基團實施保護(亦參照在端基異構中心之脫氧反應,反應圖30)。However, this alkylated form is generally not unsuitable (in particular) for the sufficient alkylation of the secondary OH groups of the carbohydrate. In addition, the degree of difficulty increases with the number of secondary OH groups to be alkylated. For certain applications, such as the alkylation of 4,6-O-ethylidene-α-D-glucopyranose as described in the prior art (JP 2005 283 632), different alkylated structural units are obtained. The mixture is sufficient. However, for the applications described herein for LC display applications, it is desirable to be able to prepare individual compounds of high purity to prepare well-defined mixtures. The method described above does not seem to be suitable for this purpose. Specifically, in a reaction medium (solvent such as dichloromethane, ether, ethyl acetate, toluene, etc.) commonly used in organic reactions, the presence of a plurality of OH groups in the "free" sugar generally hinders sufficient synthesis treatment. Ability. Thus, one of the methods of sugar chemistry is first to protect, and in many cases to protect all OH groups first (see also the deoxygenation reaction at the terminal isomerization center, reaction Figure 30 ).

達成與烷基化試劑(例如烷基溴化物)較佳反應性之一種方式在於使用糖苷(例如烷基糖苷,例如化合物40)作為共反應物。該等化合物具有足夠的反應性。使用烷基溴化物之烷基糖苷之徹底烷基化反應已闡述於下列文獻中:[a)J. Slawomir,Bull. Pol. Ac. Sci. 1988,36,327-332. b) R. Nouguier,C. Medani,Tetrahedron Lett. 1987,28,319-320.c) M. Goebel,I. Ugi,Synthesis 1991,1095-1098]。術語糖苷通常應用於在端基異構中心帶有非游離羥基官能基之取代基的化合物。烷基糖苷係藉由在酸存在下使糖與醇反應來容易地獲得。此係縮醛化反應。多種簡單糖苷可自市面購得。One way to achieve better reactivity with an alkylating agent such as an alkyl bromide is to use a glycoside (e.g., an alkyl glycoside, such as compound 40 ) as a co-reactant. These compounds are sufficiently reactive. The thorough alkylation of alkyl glycosides using alkyl bromides has been described in the following literature: [a) J. Slawomir, Bull. Pol. Ac. Sci. 1988 , 36, 327-332. b) R. Nouguier, C Medani, Tetrahedron Lett. 1987 , 28, 319-320.c) M. Goebel, I. Ugi, Synthesis 1991 , 1095-1098]. The term glycoside is generally applied to compounds having a substituent with a non-free hydroxy function at the anomeric center. Alkyl glycosides are readily obtained by reacting a sugar with an alcohol in the presence of an acid. This is a acetalization reaction. A variety of simple glycosides are commercially available from the market.

反應圖12:甲基糖苷40之合成及與36型受保護溴代烷醇之反應,以L-(+)-阿拉伯糖(35)為例。WReaction Scheme 12: Synthesis of methyl glycoside 40 and reaction with a type 36 protected bromoalkanol, taking L-(+)-arabinose (35) as an example. W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

然後,此處使用受保護溴代烷醇36(PG=保護基團)及氫化鈉(作為鹼)對甲基糖苷40實施烷基化。然後可再次利用酸催化使甲基糖苷41裂解。隨後,其餘OH官能基仍具有受保護之間隔基團。此過程可使用化合物43以縮醛化反應實施,或可使用化合物36a以烷基化反應形式來實施。除在通常位置外,此處亦能附接其他間隔基團。因此,舉例而言,可附接具有不同間隔基團長度q1之基團。q1表示介於1與24之間、較佳介於1與12之間的整數。在去保護後,可實施酯化,得到較佳之丙烯酸酯。The methyl glycoside 40 is then alkylated here using a protected bromoalkanol 36 (PG = protecting group) and sodium hydride (as a base). The methyl glycoside 41 can then be cleaved again using acid catalysis. Subsequently, the remaining OH functional groups still have protected spacer groups. This process can be carried out using the compound 43 in an acetalization reaction, or can be carried out using the compound 36a in the form of an alkylation reaction. Other spacer groups can be attached here except in the usual position. Thus, for example, groups having different spacer group lengths q1 can be attached. Q1 represents an integer between 1 and 24, preferably between 1 and 12. After deprotection, esterification can be carried out to give a preferred acrylate.

可進一步簡化反應順序(參照反應圖13)。因此,舉例而言,可在第一步驟中引入具有保護基團之間隔基團。The reaction sequence can be further simplified (refer to Reaction Scheme 13). Thus, for example, a spacer group having a protecting group can be introduced in the first step.

反應圖13:糖苷44之合成及與36型受保護溴代烷醇之反應,以L-(+)-阿拉伯糖(35)為例。WReaction Scheme 13: Synthesis of glycoside 44 and reaction with a type 36 protected bromoalkanol, taking L-(+)-arabinose (35) as an example. W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

可在端基異構中心進行縮醛化反應之其他較佳官能化及可進一步官能化之共反應物繪示於反應圖14中。Other preferred functionalizations and further functionalized co-reactants which can be subjected to acetalization at the anomeric center are shown in Figure 14 .

反應圖14:各種糖苷46、48、50之合成,以D-(+)-木糖(1)為例Reaction Figure 14: Synthesis of various glycosides 46, 48, 50, taking D-(+)-xylose (1) as an example

與ω-溴代烷醇45之反應Reaction with ω-bromoalkanol 45

與丙烯酸ω-羥基烷基酯47之反應Reaction with ω-hydroxyalkyl acrylate 47

與1,ω-二醇49之反應Reaction with 1,ω-diol 49

較佳者亦為其中在端基異構中心存在其他基團R1-[A1-Z1]x-之化合物。此處尤佳為烷基及液晶原基團。例如經由橋鍵進行連接(參照反應圖15)。Preferred are also compounds in which other groups R 1 -[A 1 -Z 1 ] x - are present in the terminal isomerization center. More preferably, it is an alkyl group and a liquid crystal original group. For example, the connection is made via a bridge key (refer to the reaction diagram 15 ).

反應圖15:各種糖苷之合成,例如化合物52及54,以L-(+)-阿拉伯糖(35)為例;可變基團係如上文所定義,或在ZReaction Figure 15: Synthesis of various glycosides, such as compounds 52 and 54, with L-(+)-arabinose (35) as an example; variable groups as defined above, or in Z 11 或ZOr Z 33 係經由橋鍵連接至環AConnected to ring A via a bridge 22 之情形下,ZIn the case of Z 11 或ZOr Z 33 連同此橋鍵一起具有ZTogether with this bridge key has Z 1-51-5 定義中之一者One of the definitions .

實例A:與醇51之反應 Example A: Reaction with alcohol 51

實例B:與醇53之反應 Example B: Reaction with alcohol 53

因此,尤佳之共反應物係烷基醇5555a、環己基醇58、環己基甲醇60、酚62及苄基醇64(參照反應圖16)、以及羧酸(此處未繪示)。Therefore, a more preferred co-reactant is alkyl alcohol 55 or 55a , cyclohexyl alcohol 58 , cyclohexylmethanol 60 , phenol 62 and benzyl alcohol 64 (see reaction scheme 16 ), and carboxylic acid (not shown here). .

反應圖16:各種尤佳糖苷56、57、59、61、63、65之合成,以L-(+)-阿拉伯糖(35)為例。WReaction Figure 16: Synthesis of various Eugenosides 56, 57, 59, 61, 63, 65, taking L-(+)-arabinose (35) as an example. W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

實例A:與烷基醇55之反應 Example A: Reaction with alkyl alcohol 55

實例B:與烷基醇55a之反應 Example B: Reaction with alkyl alcohol 55a

實例C:與環己醇58之反應 Example C: Reaction of 58 with cyclohexanol

實例D:與環己基甲醇60之反應 Example D: Reaction with cyclohexylmethanol 60

實例E:與酚62之反應 Example E: Reaction with phenol 62

實例F:與苄基醇64之反應 Example F: Reaction with benzyl alcohol 64

上文及下文子式之基團Above and below Group

較佳表示選自下列子式之基團:Preferably, it represents a group selected from the group consisting of:

然後可使化合物56、57、59、61、63及65或自其他糖獲得之化合物適當官能化(參見例如反應圖1-13之方法),例如如反應圖17中所示。Compounds 56, 57, 59, 61, 63 and 65 or compounds obtained from other sugars can then be suitably functionalized (see, for example, the method of Reaction Figures 1-13), for example as shown in Reaction Scheme 17.

反應圖17:在端基異構中心上含有取代基RReaction Figure 17: Substituent R on the terminal isomerization center 11 -[A-[A 11 -Z-Z 11 ]] xx -之化合物I之合成(尤其=67及69)。W- Synthesis of Compound I (especially = 67 and 69). W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 ;基團之定義參見反應圖15。See Figure 15 for the definition of the group.

實例A:與ω-溴鏈烷酸2之反應 Example A: Reaction with ω-bromoalkanoic acid 2

實例B:烯丙基化,硼氫化途徑 Example B: Allylation, borohydride pathway

該等糖含有具有不同反應性之羥基官能基。己糖(例如D-(+)-葡萄糖(70))含有三種具有不同反應性之醇基團(參照圖1)-一級羥基官能基、二級羥基官能基及端基異構羥基官能基。上文已論述端基異構中心之特殊反應性。The sugars contain hydroxyl functional groups having different reactivity. Hexoses (e.g., D-(+)-glucose (70) ) contain three alcohol groups having different reactivity (see Figure 1 ) - a primary hydroxyl functional group, a secondary hydroxyl functional group, and an anomeric hydroxy functional group. The specific reactivity of the terminal isomerization centers has been discussed above.

圖1:糖中之不同羥基官能基,此處以D-(+)-葡萄糖(70)為例Figure 1: Different hydroxy functional groups in sugar, here D-(+)-glucose (70) as an example

一般而言,上文所給出之所有反應均可利用D-(+)-葡萄糖(70)及其他己糖來實施,且相應化合物I可以此方式獲得。仍然以反應圖18中之兩個實例加以說明。In general, all of the reactions given above can be carried out using D-(+)-glucose (70) and other hexoses, and the corresponding compound I can be obtained in this manner. Still illustrated by the two examples in Figure 18 of the reaction .

反應圖18:D-(+)-葡萄糖(70)反應得到化合物I(尤其=71及72)之實例。WReaction Scheme 18: D-(+)-glucose (70) reaction gives examples of Compound I (especially = 71 and 72). W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

實例A:與ω-溴烷醯氯6之完全反應 Example A: Complete reaction with ω-bromoanthracene chloride 6

實例B:所有側面上之1,3-二醇間隔基團均經烯丙基化 Example B: 1,3-diol spacer groups on all sides are allyylated

此處亦可再次利用羥基官能基之不同反應性以引入不同間隔基團(鏈長、類型),具體而言若使用保護基團。以反應圖19中之實例加以說明。The different reactivity of the hydroxyl functional groups can also be utilized here again to introduce different spacer groups (chain length, type), in particular if a protecting group is used. It is illustrated by the example in the reaction diagram of FIG .

端基異構中心可如上文以烷基糖苷形式進行保護,或可直接引入期望間隔基團或前體(化合物73,q1係介於1與24之間、較佳介於1與12之間的整數)。引入三苯甲基保護基團得到化合物74體現出一級與二級OH基團之間的差異。然後可(例如)使用溴鏈烷酸將二級OH基團酯化。然後去除75中之三苯甲基保護基團,並可將適宜基團附接至一級OH基團。此處再次選擇酯化,此時使用具有不同鏈長s1之ω-溴鏈烷酸2a。s1係介於1與24之間、較佳介於1與12之間的整數。最後,藉由與丙烯酸4反應引入所有可聚性基團,得到化合物77The anomeric center may be protected as an alkyl glycoside as described above, or may be introduced directly into a desired spacer or precursor (compound 73 , q1 is between 1 and 24, preferably between 1 and 12) Integer). The introduction of a trityl protecting group gives compound 74 the difference between the primary and secondary OH groups. The secondary OH group can then be esterified, for example, using a bromoalkanoic acid. The trityl protecting group in 75 is then removed and a suitable group can be attached to the primary OH group. The esterification is again selected here, in which case ω-bromo alkanoic acid 2a having a different chain length s1 is used. S1 is an integer between 1 and 24, preferably between 1 and 12. Finally, all of the polymerizable groups are introduced by reaction with acrylic acid 4 to give compound 77 .

反應圖19:D-(+)-葡萄糖(70)反應之保護基團策略。WReaction Figure 19: Protecting group strategy for D-(+)-glucose (70) reaction. W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

熟習此項技術之人員將能夠以適宜方式對所展示之起始材料、試劑及方法進行組合或添加並由此獲得多種可能之I型化合物。Those skilled in the art will be able to combine or add the starting materials, reagents and methods shown in a suitable manner and thereby obtain a variety of possible Type I compounds.

一級OH基團亦係附接其他基團R1-[A1-Z1]x-或R2-[A3-Z3]y-(較佳烷基及液晶原基團)之較佳位置。為此,可使用(例如)四苄基醚80。其係自D-(+)-葡萄糖(70)獲得。首先,以三苯甲基醚形式對C6-OH基團進行保護,且然後使其他位置苄化。在去除三苯甲基後,獲得80(參照反應圖20)。The primary OH group is also preferably attached to other groups R 1 -[A 1 -Z 1 ] x - or R 2 -[A 3 -Z 3 ] y - (preferably alkyl and liquid crystal original groups) position. For this purpose, for example, tetrabenzyl ether 80 can be used. It is obtained from D-(+)-glucose (70). First, the C6-OH group is protected as a trityl ether and then the other positions are benzylated. After removing the trityl group, 80 was obtained (refer to Reaction Scheme 20 ).

反應圖20:用於C6-OH基團衍生/官能化之較佳中間體之合成,以D-(+)-葡萄糖(70)之反應為例Reaction Scheme 20: Synthesis of a preferred intermediate for C6-OH group derivatization/functionalization, taking D-(+)-glucose (70) reaction as an example

在最簡單之情形下,官能化係藉由以下方式實施:使用烷基鹵化物(例如碘化物81)、甲苯磺酸酯或三氟甲磺酸酯對一級OH基團實施烷基化反應(參照反應圖21中之實例)。隨後苄基解離,並相應地對化合物83之其餘OH官能基進行轉化。In the simplest case, the functionalization is carried out by alkylating the primary OH group with an alkyl halide (eg iodide 81 ), tosylate or triflate ( Refer to the example in Reaction Scheme 21 ). The benzyl group is then cleaved and the remaining OH functional groups of compound 83 are converted accordingly.

反應圖21:藉由烷基化反應使C6-OH官能化(較佳反應順Reaction Figure 21: Functionalization of C6-OH by alkylation (better reaction 序之實例);基團之定義參見反應圖15。Examples of the order); see Figure 15 for the definition of the group.

此處及下文基團X11至X55連同毗鄰基團-O-一起採用選自基團X或X1至X5之定義之含義。因此,-O-X11-部分對應於(例如)式I中之基團-X-或式IA至IC中之X1Here and hereinafter the groups X 11 to X 55 together with the adjacent group -O- are taken from the meaning of the definition of the group X or X 1 to X 5 . Thus, the -OX 11 - moiety corresponds to, for example, the group -X- in formula I or X 1 in formulas IA to IC.

又一較佳反應係使用羧酸85將C6-OH官能基酯化(參照反應圖22)。A further preferred reaction esterifies the C6-OH functional group with a carboxylic acid 85 (see Reaction Scheme 22 ).

反應圖22:藉由酯化使C6-OH官能化(較佳反應順序之實例);基團之定義參見反應圖15。Reaction Scheme 22: Functionalization of C6-OH by esterification (examples of preferred reaction sequences); see Figure 15 for definition of groups.

亦可使用適宜醇99(例如,但具體而言酚89)實施Mitsunobu酯化(參照反應圖23)。在去除苄基保護基團後,獲得中間體91,然後可將其轉化為92型化合物。Mitsunobu esterification can also be carried out using a suitable alcohol 99 (for example, but specifically phenol 89 ) (see Reaction Scheme 23 ). After removal of the benzyl protecting group, intermediate 91 is obtained which can then be converted to the type 92 compound.

反應圖23:藉由酯化使C6-OH官能化(較佳反應順序之實例)。Reaction Scheme 23: Functionalization of C6-OH by esterification (examples of preferred reaction sequences).

此外,可將C6-羥基轉化為良好離去基團(例如溴化物或甲苯磺酸酯)。然後可進一步使用親核試劑(較佳使用含碳親核試劑(例如格氏試劑94)及含氧親核試劑(例如自酚89、醇99或羧酸85獲得者)將諸如9398等化合物轉化為其他較佳之中間體969110087In addition, the C6-hydroxy group can be converted to a good leaving group (e.g., bromide or tosylate). Further, a nucleophilic reagent (preferably using a carbon-containing nucleophile (for example, Grignard reagent 94 ) and an oxygen-containing nucleophile (for example, a phenol 89 , an alcohol 99 or a carboxylic acid 85 ) may be further used, such as 93 or 98 . The compound is converted to other preferred intermediates 96 , 91 , 100 and 87 .

反應圖24:將C6-羥基轉化為離去基團(此處為甲苯磺酸酯或溴化物)及與親核試劑之反應;基團之定義參見反應圖15。Reaction Scheme 24: Conversion of a C6-hydroxy group to a leaving group (here a tosylate or bromide) and reaction with a nucleophile; the definition of the group is shown in Figure 15.

A:甲苯磺酸酯93之合成及與格氏試劑94之反應A: Synthesis of tosylate 93 and reaction with Grignard reagent 94

B:溴化物98之合成及與酚89之反應B: Synthesis of bromide 98 and reaction with phenol 89

C:溴化物98與醇99之反應C: Reaction of bromide 98 with alcohol 99

D:溴化物98與羧酸85之反應D: Reaction of bromide 98 with carboxylic acid 85

80氧化(例如Swern氧化)得到醛102。其係Wittig反應(參照反應圖25)或加成反應之較佳受質。Wittig反應得到含有-C=C-橋鍵之化合物,在後續氫化中亦可將-C=C-橋鍵轉化為-CH2-CH2-橋鍵。以此方式,亦可引入簡單烷基。Oxide 80 (e.g. Swern oxidation) to give the aldehyde 102. It is a better substrate for the Wittig reaction (see Figure 25 ) or for the addition reaction. Wittig reaction to give the compound C- bridge containing -C =, in the subsequent hydrogenation -C = C- bridge bonds may be converted to -CH 2 -CH 2 - bridge. In this way, a simple alkyl group can also be introduced.

反應圖25:醛102之合成及與試劑103之反應(Wittig反應);基團之定義參見反應圖15。Reaction Scheme 25: Synthesis of aldehyde 102 and reaction with reagent 103 (Wittig reaction); for the definition of the group, see Reaction Scheme 15.

若目的係獲得含有雙鍵之化合物,則必須使用其他保護基團。If the target is to obtain a compound containing a double bond, then other protecting groups must be used.

反應圖26:醛108之合成及利用Wittig反應轉化為含有-C=C-橋鍵之化合物I(尤其=112);基團之定義參見反應圖15。Reaction Scheme 26: Synthesis of aldehyde 108 and conversion to a compound I containing a -C=C-bridge by Wittig reaction (especially = 12); for the definition of the group, see Figure 15.

若意欲獲得含有酯鍵之化合物,則使用羧酸113(參照 應圖27)。此等羧酸可自化合物80藉由TEMPO氧化而獲得。使用醇99進行酯化,得到化合物114。在去除苄基後,可再次附接間隔基團及可聚性基團。If intended to obtain the compound containing an ester bond, the carboxylic acid 113 (see FIG. 27 reactions). These carboxylic acids can be obtained from the oxidation of compound 80 by TEMPO. Esterification using alcohol 99 gives compound 114 . After removal of the benzyl group, the spacer group and the polymerizable group can be attached again.

反應圖27:羧酸113之合成及使用醇/酚99進行酯化。在C6處含有酯橋鍵之化合物I(尤其=115)之合成;基團之定義參見反應圖15。Reaction Scheme 27: Synthesis of Carboxylic Acid 113 and esterification using alcohol/phenol 99. The synthesis of compound I (especially = 115) containing an ester bridge at C6; see Figure 15 for the definition of the group.

其中基團R1-[A1-Z1]x-或R2-[A3-Z3]y-係在端基異構中心或經由己糖之一級OH基團引入之化合物I係其中尤佳之化合物。Wherein the group R 1 -[A 1 -Z 1 ] x - or R 2 -[A 3 -Z 3 ] y - is a compound I which is introduced at an anomeric center or via a OH group Especially good compound.

然而,在糖骨架不同位置附接有基團R1-[A1-Z1]x-或R2-[A3-Z3]y-之化合物亦為較佳之化合物(參照,例如子結構IBIC)。對於其合成而言,在某些情形下需要對所存在之三個不同二級OH官能基進行區分。出於此目的,熟習此項技術之人員可採用很多種來自糖化學之方法。一種可能性(其中使用環狀縮醛)示於下文中,以D-(+)-半乳糖(116)之反應為例。首先將其轉化為(例如)相應甲基糖苷117。可以丙酮化合物(化合物118)形式有選擇地對C4及C5上彼此處於順位之OH基團進行保護。然後再次使用三苯甲基保護基團對一級及二級OH基團進行區分。然後使化合物119中之其餘OH基團進行適宜衍生。然後可去除保護基團,得到121。亦可依序實施去保護以附接不同間隔基團。為簡便起見,此處未繪示此可能性。然後可(例如)使用上文所指出之方法實施官能化得到可聚性化合物122亦或123However, a compound having a group R 1 -[A 1 -Z 1 ] x - or R 2 -[A 3 -Z 3 ] y - attached at a different position of the sugar skeleton is also a preferred compound (see, for example, a substructure) IB and IC ). For its synthesis, it is necessary in some cases to distinguish between the three different secondary OH functional groups present. For this purpose, a wide variety of methods from sugar chemistry can be employed by those skilled in the art. One possibility, in which a cyclic acetal is used, is shown below, taking the reaction of D-(+)-galactose (116) as an example. It is first converted to, for example, the corresponding methyl glycoside 117 . The OH groups in the C4 and C5 groups may be selectively protected in the form of an acetonide (compound 118 ). The primary and secondary OH groups are then distinguished again using a trityl protecting group. The remaining OH groups in compound 119 are then suitably derivatized. The protecting group can then be removed to give 121 . Deprotection can also be performed sequentially to attach different spacer groups. For the sake of brevity, this possibility is not shown here. Functionalization can then be carried out, for example, using the methods indicated above to give polymerizable compound 122 or 123 .

反應圖28:糖骨架C6上含有取代基RReaction Figure 28: Substituent R on the sugar skeleton C6 11 -[A-[A 11 -Z-Z 11 ]] xx -或R-or R 22 -[A-[A 33 -Z-Z 33 ]] yy -之化合物I(尤其=122或123)之合成,以D-(+)-半乳糖(116)為例- Synthesis of Compound I (especially = 122 or 123), taking D-(+)-galactose (116) as an example

此外,可將相鄰OH基團轉化為環氧化物。可使用親核試劑使其開環。此同樣可達成兩個二級OH基團之區分,且已指出亦可在SN2反應意義上形成CC鍵之又一可能性。實例示於反應圖29中。此處,將自D-(+)-葡萄糖之甲基糖苷形成之亞苄基縮醛124轉化為環氧化物125。然後(例如)使用格氏試劑126使其開環。然後可在解離後每一情形下使127中之OH基團適當官能化。In addition, adjacent OH groups can be converted to epoxides. A nucleophile can be used to open the ring. This also makes it possible to distinguish between two secondary OH groups and has indicated a further possibility of forming a CC bond in the sense of S N 2 reaction. An example is shown in Reaction Scheme 29 . Here, the benzal acetal 124 formed from the methyl glycoside of D-(+)-glucose is converted to the epoxide 125 . The ring is then opened, for example, using Grignard reagent 126 . The OH groups in 127 can then be suitably functionalized in each case after dissociation.

反應圖29:環氧化物125之合成及反應Reaction Figure 29: Synthesis and reaction of epoxide 125

尤佳者亦為其中端基異構中心上之基團R1-[A1-Z1]x-表示氫的化合物。該等化合物同樣可自糖藉由端基異構中心之脫氧反應來獲得。通常借助自由基(例如使用氫化錫)實施脫氧。一種可能之反應順序示於反應圖30中,以L-(+)-阿拉伯糖(35)之反應為例。首先,將所有OH基團醯化,並藉由與PBr3反應溴化端基異構中心。然後使用三丁基氫化錫對所得化合物128實施脫氧。在酯基團水解後,獲得適宜單元129,以用於合成化合物I(=反應圖30中之130)。當然,在其他合成步驟中亦可以類似形式實施脫氧反應。Also preferred are compounds wherein the group R 1 -[A 1 -Z 1 ] x - on the terminal anomeric center represents hydrogen. These compounds are also obtainable from the deoxygenation reaction of sugars by an anomeric center. Deoxygenation is usually carried out by means of free radicals, for example using tin hydride. One possible reaction sequence is shown in Reaction Scheme 30 , taking the reaction of L-(+)-arabinose (35) as an example. First, all the OH groups acylated, by reaction with PBr 3 and brominated anomeric center. The resulting compound 128 was then deoxygenated using tributyltin hydride. After hydrolysis of the ester group, suitable unit 129 is obtained for the synthesis of compound I (= 130 in reaction diagram 30 ). Of course, the deoxygenation reaction can also be carried out in a similar manner in other synthetic steps.

反應圖30:端基異構中心之脫氧反應,以L-(+)-阿拉伯糖(35)為例Reaction Figure 30: Deoxygenation of an anomeric center, taking L-(+)-arabinose (35) as an example

有關端基異構中心官能化之又一較佳形式係其氟化。此能夠達成(例如)與習用高度氟化LC材料甚至更佳之相容性。糖基氟化物同樣可自乙酸酯(例如)藉由與HF/吡啶錯合物反應來獲得(參照反應圖31)。A further preferred form of functionalization of the anomeric center is fluorination. This enables, for example, even better compatibility with conventional highly fluorinated LC materials. The glycosyl fluoride can also be obtained from an acetate (for example) by reaction with an HF/pyridine complex (see Reaction Scheme 31 ).

反應圖31:糖基氟化物132之合成,以L-(+)-阿拉伯糖(35)為例Reaction Figure 31: Synthesis of glycosyl fluoride 132, taking L-(+)-arabinose (35) as an example

又一較佳反應係在端基異構中心與穩定內鎓鹽之Wittig-Horner-Emmons反應。以此方式,能夠獲得C-糖苷(例如134),自其可建構間隔基團。實例示於反應圖32中。A further preferred reaction is the Wittig-Horner-Emmons reaction at the anomeric center with a stable ylide. In this way, a C-glycoside (e.g., 134 ) can be obtained from which a spacer group can be constructed. An example is shown in Reaction Scheme 32 .

反應圖32:在端基異構中心之Wittig-Horner-Emmons反應。Reaction Figure 32: Wittig-Horner-Emmons reaction at the endo-isomerization center.

此處將再次對其他較佳之間隔基團及其合成應予以論述。以上實例已表明含有式-Sp"-OH之擴展OH基團之化合物或含有-Sp"-Br-單元(其中Sp"在每一情形下皆表示具有2個或更多個C原子之1-氧雜烯基鏈)之類似溴化物係重要中間體(例如化合物915)。其可鍵結其他基團。Other preferred spacer groups and their synthesis will be discussed again herein. The above examples have shown that a compound containing an extended OH group of the formula -Sp"-OH or a -Sp"-Br- unit (wherein Sp" is in each case represented by two or more C atoms An analogous bromide-based important intermediate (eg, compound 9 , 15 ) of the oxacycloalkenyl chain. It can bond other groups.

化合物(例如9)可(例如)依次與ω-溴鏈烷酸2或ω-溴烷醯基氯6反應(參照反應圖33)。The compound (for example, 9 ) can be, for example, sequentially reacted with ω-bromoalkanoic acid 2 or ω-bromoalkyl fluorenyl chloride 6 (refer to Reaction Scheme 33 ).

反應圖33:相對複雜間隔基團之合成實例。化合物136之合成。WReaction Scheme 33: Synthesis example of relatively complex spacer groups. Synthesis of Compound 136. W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

可建構相對複雜的間隔基團或可以此方式或以類似方式擴展鏈。此處,熟習此項技術之人員應能夠將適宜方法彼此組合。此等亦包括使用α-溴甲基乙酸酯137實施烷基化反應及溴化物與(例如)(聚)伸乙基二醇141之反應。Relatively complex spacer groups can be constructed or the chain can be extended in this manner or in a similar manner. Here, those skilled in the art should be able to combine suitable methods with each other. These also include the alkylation reaction using alpha-bromomethyl acetate 137 and the reaction of bromide with, for example, (poly)ethylidene glycol 141 .

可對使用α-溴甲基乙酸酯烷基化反應之產物137實施水解,且可(例如)使用丙烯酸(2-羥基伸烷基)酯47經由酯化直接附接丙烯酸酯基團。Hydrolysis of the product 137 using an alpha-bromomethyl acetate alkylation reaction can be carried out, and the acrylate group can be directly attached via esterification, for example, using (2-hydroxyalkylalkyl) acrylate 47 .

可將與(聚)伸乙基二醇141反應之產物直接轉化為丙烯酸酯。The product reacted with (poly)ethyl 141 can be directly converted to an acrylate.

反應圖34:相對複雜間隔基團之合成。化合物140及143之合成。WReaction Scheme 34: Synthesis of relatively complex spacer groups. Synthesis of compounds 140 and 143. W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

使用α-溴甲基乙酸酯137之烷基化反應及後續反應。The alkylation reaction of α-bromomethyl acetate 137 and subsequent reaction were carried out.

與伸乙基二醇141之反應。Reaction with ethylene glycol 141 .

使用α-溴甲基乙酸酯137之烷基化反應亦適於例如自糖苷(例如144)開始在所有側面上附接較佳之間隔基團Sp'X=OCH2C(O)O(CH2)2-(參照反應圖35)。The alkylation reaction using alpha-bromomethyl acetate 137 is also suitable, for example, for attachment of a preferred spacer group Sp'X=OCH 2 C(O)O(CH) on all sides starting from a glycoside (e.g., 144 ). 2 ) 2 - (Refer to Figure 35 ).

反應圖35:其中Sp'X=OCHReaction Figure 35: where Sp'X=OCH 22 C(O)O(CHC(O)O(CH 22 )) 22 -之化合物I(尤其=147)之合成。甲基糖苷144之反應實例。W- Synthesis of Compound I (especially = 147). An example of the reaction of methyl glycoside 144. W 11 =R。R較佳為H或CH=R. R is preferably H or CH 33 .

因此,本發明通常進一步係關於製備如針對化合物所定義之式I化合物之方法,其係藉由單糖或二糖(具體而言上文所提及或繪示之糖)及其衍生物之衍生來實施。Accordingly, the invention is generally further directed to a process for the preparation of a compound of formula I as defined for a compound by means of a monosaccharide or a disaccharide (specifically the sugars mentioned or depicted above) and derivatives thereof Derived to implement.

本發明進一步係關於式I化合物在液晶介質中之用途,具體而言在該等介質中作為聚合物之用途。該等化合物亦可用作穩定液晶相(具體而言藍相)之聚合物。此類用途已為吾人習知且闡述於所引用文獻及藍相事例之實例部分中。一般而言,介質在處於藍相之溫度下發生聚合。從而在很大程度上加寬了此相之穩定性範圍。The invention further relates to the use of the compounds of the formula I in liquid-crystalline media, in particular as polymers in such media. These compounds can also be used as polymers for stabilizing the liquid crystal phase, specifically the blue phase. Such uses are well known to us and are set forth in the Examples section of the cited documents and blue phase examples. In general, the medium polymerizes at a temperature at the blue phase. This greatly broadens the range of stability of this phase.

較佳液晶介質之特徵在於在藉由聚合穩定藍相後,其至少在15℃至30℃(較佳10℃至40℃、尤佳0℃至50℃、且極佳-10℃至60℃)範圍內具有藍相。Preferably, the liquid crystal medium is characterized in that it is at least 15 ° C to 30 ° C (preferably 10 ° C to 40 ° C, particularly preferably 0 ° C to 50 ° C, and preferably -10 ° C to 60 ° C after stabilizing the blue phase by polymerization). ) has a blue phase within the range.

本發明同樣係關於包含聚合物或包含至少一種式I之非聚合單體或二者之液晶介質,該聚合物包含至少一種式I之單體組份。The invention likewise relates to a liquid-crystalline medium comprising a polymer or comprising at least one non-polymeric monomer of the formula I or both, the polymer comprising at least one monomer component of the formula I.

本發明之尤佳介質係下文所提及者:該介質包含一或多種單反應性單體或自一或多種單反應性單體及視情況其他單體建構之聚合物。單反應性單體之比例較佳為1%至15%,尤佳為2%至12%。較佳之單反應性單體係彼等具有式I*者(如下文所指出),其中個別基團尤佳採用對式I*較佳之實施例且僅基團Ra具有可聚性。尤佳者係其中n=1且B1/B2表示環己烷-1,4-二基或1,4-伸苯基之式I*化合物。Particularly preferred media of the invention are those mentioned below: the medium comprises one or more monoreactive monomers or polymers constructed from one or more monoreactive monomers and optionally other monomers. The proportion of the monoreactive monomer is preferably from 1% to 15%, particularly preferably from 2% to 12%. Preferred single-reacting single systems have those of formula I* (as indicated below), with individual groups being particularly preferred for the preferred embodiment of formula I* and only the group Ra is polymerizable. More preferred are compounds of the formula I* wherein n = 1 and B 1 /B 2 represents cyclohexane-1,4-diyl or 1,4-phenylene.

除上文所提及之單反應性單體外,該介質包含一或多種用作交聯劑之化合物,該等化合物之區別在於複數個反應性基團。此等包括式I化合物。In addition to the single reactive monomers mentioned above, the medium comprises one or more compounds useful as crosslinkers, the compounds being distinguished by a plurality of reactive groups. These include compounds of formula I.

該介質包含一或多種二反應性單體或自一或多種二反應性單體及視情況其他單體建構之聚合物。二反應性單體之比例較佳為0%至9%,尤佳為0%至5%。在較佳實施例中,二反應性單體部分地或完全由含有3個或更多個反應性基團之本發明式I化合物替代。The medium comprises one or more di-reactive monomers or a polymer constructed from one or more di-reactive monomers and optionally other monomers. The proportion of the two reactive monomers is preferably from 0% to 9%, particularly preferably from 0% to 5%. In a preferred embodiment, the direactive monomer is partially or completely replaced by a compound of formula I of the invention containing three or more reactive groups.

單-及二反應性單體之總和較佳為3%至17%,尤佳為6-14%。The sum of the mono- and di-reactive monomers is preferably from 3% to 17%, particularly preferably from 6 to 14%.

亦可使用三反應性或多反應性(>3)單體。在某些或全部情形下,三反應性或多反應性(>3)單體較佳屬於式I化合物。It is also possible to use three reactive or polyreactive (>3) monomers. In some or all cases, a tri-reactive or polyreactive (>3) monomer is preferred to be a compound of formula I.

單反應性單體與交聯劑之比率較佳介於3:1與1:1之間。該比率取決於所涉及交聯劑之反應基團之數量。在使用四反應性交聯劑之情形下,該比率尤佳介於3:1與2:1之間,且在使用二反應性交聯劑之情形下,該比率尤佳介於1.5:1與1:1之間。The ratio of monoreactive monomer to crosslinker is preferably between 3:1 and 1:1. This ratio depends on the number of reactive groups of the crosslinking agent involved. In the case of using a four-reactive cross-linking agent, the ratio is particularly preferably between 3:1 and 2:1, and in the case of using a two-reactive cross-linking agent, the ratio is particularly preferably between 1.5:1 and 1. Between:1.

單反應性單體具有(例如)下式之結構Ra-Sp-P,其中P表示可聚性基團,Sp表示間隔基團或單鍵,且Ra表示具有至少3個C原子之有機基團。The monoreactive monomer has, for example, the structure R a -Sp-P of the following formula, wherein P represents a polymerizable group, Sp represents a spacer group or a single bond, and R a represents an organic group having at least 3 C atoms Group.

基團Ra可為所謂的液晶原基團,其通常含有一或多個環、或簡單通常鏈狀之非液晶原基團。The group R a may be a so-called liquid crystal primordial group, which usually contains one or more rings, or a simple, usually chain-like, non-liquid crystal primordial group.

非液晶原基團較佳為具有1個至30個C原子之直鏈或具支鏈烷基,另外,其中一或多個不毗鄰CH2基團可以O及/或S原子彼此不直接連接之方式各自彼此獨立地經由-C(R0)=C(R00)-、-C≡C-、-N(R00)-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-替代,且另外,其中一或多個H原子可由F、Cl、Br、I或CN替代。The non-liquid crystal primordial group is preferably a linear or branched alkyl group having 1 to 30 C atoms, and further, one or more of the non-contiguous CH 2 groups may be directly connected to each other by O and/or S atoms. The manners are each independently of each other via -C(R 0 )=C(R 00 )-, -C≡C-, -N(R 00 )-, -O-, -S-, -CO-, -CO- O-, -O-CO-, -O-CO-O- is substituted, and in addition, one or more H atoms may be replaced by F, Cl, Br, I or CN.

P及Sp之較佳含義對應於下文針對式I*所指出之含義。The preferred meanings of P and Sp correspond to the meanings indicated below for formula I*.

含有一個、兩個或更多個可聚性基團之較佳液晶原單體由式I*來表徵Preferred liquid crystal monomers having one, two or more polymerizable groups are characterized by Formula I*

Ra-B1-(Zb-B2)m-Rb I*R a -B 1 -(Z b -B 2 ) m -R b I*

其中個別基團具有以下含義:Ra及Rb 各自彼此獨立地表示P、P-Sp-、H、鹵素、SF5、NO2、碳基或烴基,其中該等基團Ra及Rb中至少一個表示或含有基團P或P-Sp-,P 每次出現時相同或不同且表示可聚性基團,Sp 每次出現時相同或不同且表示間隔基團或單鍵,B1及B2 各自彼此獨立地表示較佳地具有4個至25個環原子之芳香族、雜芳香族、脂環族或雜環基團,其亦可含有稠環且其亦可經L單取代或多取代,L 表示P-Sp-、H、OH、CH2OH、鹵素、SF5、NO2、碳基或烴基,Zb 每次出現時相同或不同且表示-O-、-S-、-CO-、-CO-O-、-OCO-、-O-CO-O-、-OCH2-、-CH2O-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-(CH2)n1-、-CF2CH2-、-CH2CF2-、-(CF2)n1-、-CH=CH-、-CF=CF-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-、CR0R00或單鍵,R0及R00 各自彼此獨立地表示H或具有1個至12個C原子之烷基,m 表示0、1、2、3或4,n1 表示1、2、3或4。Wherein individual groups have the following meanings: R a and R b each independently represent P, P-Sp-, H, halogen, SF 5 , NO 2 , carbon or hydrocarbyl, wherein such radicals R a and R b At least one of or represents a group P or P-Sp-, each occurrence of P is the same or different and represents a polymerizable group, each occurrence of Sp is the same or different and represents a spacer group or a single bond, B 1 And B 2 each independently represent an aromatic, heteroaromatic, alicyclic or heterocyclic group preferably having 4 to 25 ring atoms, which may also contain a fused ring and which may also be monosubstituted by L Or polysubstituted, L represents P-Sp-, H, OH, CH 2 OH, halogen, SF 5 , NO 2 , carbon or hydrocarbyl, and Z b is the same or different at each occurrence and represents -O-, -S- , -CO-, -CO-O-, -OCO-, -O-CO-O-, -OCH 2 -, -CH 2 O-, -SCH 2 -, -CH 2 S-, -CF 2 O- , -OCF 2 -, -CF 2 S-, -SCF 2 -, -(CH 2 ) n1 -, -CF 2 CH 2 -, -CH 2 CF 2 -, -(CF 2 ) n1 -, -CH= CH-, -CF=CF-, -C≡C-, -CH=CH-COO-, -OCO-CH=CH-, CR 0 R 00 or a single bond, and R 0 and R 00 each independently represent H Or an alkyl group having 1 to 12 C atoms, m Indicates 0, 1, 2, 3 or 4, and n1 represents 1, 2, 3 or 4.

尤佳之式I*化合物係彼等其中該等基團中之一或多者表示以下意義者:Ra及Rb 各自彼此獨立地表示P、P-Sp-、H、F、Cl、Br、I、-CN、-NO2、-NCO、-NCS、-OCN、-SCN、SF5或具有1個至25個C原子之直鏈或具支鏈烷基,另外,其中一或多個不毗鄰CH2基團可以O及/或S原子彼此不直接連接之方式各自彼此獨立地由-C(R0)=C(R00)-、-C≡C-、-N(R00)-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-替代,且另外,其中一或多個H原子可由F、Cl、Br、I、CN、P或P-Sp-替代,其中基團Ra及Rb中至少一個表示或含有基團P或P-Sp-,B1及B2 各自彼此獨立地表示1,4-伸苯基、萘-1,4-二基、萘-2,6-二基、菲-2,7-二基、蒽-2,7-二基、茀-2,7-二基、香豆素、黃酮(另外,其中該等基團中之一或多個CH基團可由N替代)、環己烷-1,4-二基(另外,其中一或多個不毗鄰CH2基團可由O及/或S替代)、1,4-伸環己烯基、二環[1.1.1]戊烷-1,3-二基、二環[2.2.2]辛烷-1,4-二基、螺[3.3]庚烷-2,6-二基、六氫吡啶-1,4-二基、十氫化萘-2,6-二基、1,2,3,4-四氫化萘-2,6-二基、二氫茚-2,5-二基或八氫-4,7-亞甲基二氫茚-2,5-二基,其中所有該等基團可未經取代或經L單-或多取代,L 表示P、P-Sp-、OH、CH2OH、F、Cl、Br、I、-CN、-NO2、-NCO、-NCS、-OCN、-SCN、-C(=O)N(Rx)2、-C(=O)Y1、-C(=O)Rx、-N(Rx)2、視情況經取代之甲矽烷基、具有6個至20個C原子之視情況經取代之芳基、或具有1個至25個C原子之直鏈或具支鏈烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰基氧基或烷氧基羰基氧基,另外,其中一或多個H原子可由F、Cl、P或P-Sp-替代,P及Sp 具有上文所給出之含義,Y1 表示鹵素,Rx 表示P、P-Sp-、H、鹵素、具有1個至25個C原子之直鏈、具支鏈或環狀烷基(另外,其中一或多個不毗鄰CH2基團可以O及/或S原子彼此不直接連接之方式由-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-替代,且另外,其中一或多個H原子可由F、Cl、P或P-Sp-替代)、具有6個至40個C原子之視情況經取代之芳基或芳基氧基、或具有2個至40個C原子之視情況經取代之雜芳基或雜芳基氧基,及/或m 表示0、1或2。Preferably, the compound of formula I* is one in which one or more of the groups represents the following meaning: R a and R b each independently represent P, P-Sp-, H, F, Cl, Br. , I, -CN, -NO 2 , -NCO, -NCS, -OCN, -SCN, SF 5 or a linear or branched alkyl group having 1 to 25 C atoms, in addition, one or more The non-adjacent CH 2 groups may be independently from each other by the manner in which O and/or S atoms are not directly connected to each other by -C(R 0 )=C(R 00 )-, -C≡C-, -N(R 00 ). -, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O- instead, and additionally, one or more of the H atoms may be F, Cl, Br, I, CN, P or P-Sp-substitution, wherein at least one of the groups R a and R b represents or contains a group P or P-Sp-, and B 1 and B 2 each independently represent 1, 4 - phenyl, naphthalene-1,4-diyl, naphthalene-2,6-diyl, phenanthrene-2,7-diyl, indole-2,7-diyl, indole-2,7-diyl, Coumarin, flavonoids (in addition, wherein one or more of the CH groups may be replaced by N), cyclohexane-1,4-diyl (in addition, one or more of which are not adjacent to the CH 2 group) Group can be replaced by O and / or S), 1,4-cyclohexenyl, bicyclo [1.1.1] pentane-1 ,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane-2,6-diyl, hexahydropyridine-1,4-diyl, dehydrogenated Naphthalene-2,6-diyl, 1,2,3,4-tetrahydronaphthalene-2,6-diyl, indoline-2,5-diyl or octahydro-4,7-methylene Hydroquinone-2,5-diyl, wherein all such groups may be unsubstituted or mono- or polysubstituted by L, and L represents P, P-Sp-, OH, CH 2 OH, F, Cl, Br, I, -CN, -NO 2 , -NCO, -NCS, -OCN, -SCN, -C(=O)N(R x ) 2 , -C(=O)Y 1 , -C(=O)R x , -N(R x ) 2 , optionally substituted methylidene, optionally substituted aryl having 6 to 20 C atoms, or linear or having 1 to 25 C atoms Branched alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy, in addition, one or more of the H atoms may be F, Cl, P or P-Sp - Substituting, P and Sp have the meanings given above, Y 1 represents halogen, R x represents P, P-Sp-, H, halogen, linear, branched or 1 to 25 C atoms cyclic alkyl groups (in addition, one or more non-adjacent CH 2 groups may be O and / or S atoms are not directly connected with each other The formula is replaced by -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-, and additionally, one or more of the H atoms may be F, Cl, P or P-Sp-substituted), optionally substituted aryl or aryloxy having 6 to 40 C atoms, or optionally substituted heteroaryl having 2 to 40 C atoms or Heteroaryloxy, and/or m represents 0, 1 or 2.

術語「碳基」表示含有至少一個碳原子之單價或多價有機基團,其中其不含其他原子(例如,-C≡C-)或視情況含有一或多個其他原子(例如,N、O、S、P、Si、Se、As、Te或Ge)(例如,羰基等)。術語「烴基」表示額外含有一或多個H原子且視情況含有一或多個雜原子(例如,N、O、S、P、Si、Se、As、Te或Ge)之碳基。The term "carbon-based" means a monovalent or polyvalent organic radical containing at least one carbon atom, wherein it is free of other atoms (eg, -C≡C-) or optionally one or more other atoms (eg, N, O, S, P, Si, Se, As, Te or Ge) (for example, carbonyl, etc.). The term "hydrocarbyl" refers to a carbon radical that additionally contains one or more H atoms and optionally one or more heteroatoms (eg, N, O, S, P, Si, Se, As, Te, or Ge).

「鹵素」表示F、Cl、Br或I,較佳為F或Cl。"Halogen" means F, Cl, Br or I, preferably F or Cl.

碳基或烴基可為飽和或不飽和基團。不飽和基團係(例如)芳基、烯基或炔基。具有3個以上C原子之碳基或烴基可為直鏈、具支鏈及/或環狀且亦可含有螺鍵或稠環。The carbyl or hydrocarbyl group can be a saturated or unsaturated group. The unsaturated group is, for example, an aryl group, an alkenyl group or an alkynyl group. The carbon group or hydrocarbon group having 3 or more C atoms may be linear, branched, and/or cyclic and may also contain a spiro bond or a fused ring.

術語「烷基」、「芳基」、「雜芳基」等亦涵蓋多價基團,例如伸烷基、伸芳基、雜伸芳基等。The terms "alkyl", "aryl", "heteroaryl" and the like also encompass polyvalent groups such as alkyl, aryl, heteroaryl and the like.

術語「芳基」表示芳香族碳基或自其衍生之基團。術語「雜芳基」表示含有一或多個雜原子之根據上文定義的「芳基」。The term "aryl" means an aromatic carbon group or a group derived therefrom. The term "heteroaryl" means an "aryl" group as defined above containing one or more heteroatoms.

較佳之碳基及烴基係具有1個至40個、較佳1個至25個、尤佳1個至18個C原子之視情況經取代之烷基、烯基、炔基、烷氧基、烷基羰基、烷氧基羰基、烷基羰基氧基及烷氧基羰基氧基;具有6個至40個、較佳6個至25個C原子之視情況經取代之芳基及芳基氧基;及具有6個至40個、較佳6個至25個C原子之視情況經取代之烷基芳基、芳基烷基、烷基芳基氧基、芳基烷基氧基、芳基羰基、芳基氧基羰基、芳基羰基氧基及芳基氧基羰基氧基。Preferred carbon-based and hydrocarbon-based alkyl, alkenyl, alkynyl, alkoxy groups having from 1 to 40, preferably from 1 to 25, particularly preferably from 1 to 18, C atoms, optionally substituted Alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy and alkoxycarbonyloxy; optionally substituted aryl and aryloxy having 6 to 40, preferably 6 to 25, C atoms And optionally substituted alkylaryl, arylalkyl, alkylaryloxy, arylalkyloxy, aryl having 6 to 40, preferably 6 to 25, C atoms Alkylcarbonyl, aryloxycarbonyl, arylcarbonyloxy and aryloxycarbonyloxy.

其他較佳之碳基及烴基團係C1-C40烷基、C2-C40烯基、C2-C40炔基、C3-C40烯丙基、C4-C40烷基二烯基、C4-C40多烯基、C6-C40芳基、C6-C40烷基芳基、C6-C40芳基烷基、C6-C40烷基芳基氧基、C6-C40芳基烷基氧基、C2-C40雜芳基、C4-C40環烷基、C4-C40環烯基等。尤佳者係C1-C22烷基、C2-C22烯基、C2-C22炔基、C3-C22烯丙基、C4-C22烷基二烯基、C6-C12芳基、C6-C20芳基烷基及C2-C20雜芳基。Other preferred group of carbon and hydrocarbon-based radical C 1 -C 40 alkyl, C 2 -C 40 alkenyl, C 2 -C 40 alkynyl, C 3 -C 40 allyl group, C 4 -C 40 alkyl di Alkenyl, C 4 -C 40 polyalkenyl, C 6 -C 40 aryl, C 6 -C 40 alkylaryl, C 6 -C 40 arylalkyl, C 6 -C 40 alkylaryloxy A C 6 -C 40 arylalkyloxy group, a C 2 -C 40 heteroaryl group, a C 4 -C 40 cycloalkyl group, a C 4 -C 40 cycloalkenyl group or the like. Particularly preferred are C 1 -C 22 alkyl, C 2 -C 22 alkenyl, C 2 -C 22 alkynyl, C 3 -C 22 allyl, C 4 -C 22 alkyldienyl, C 6 -C 12 aryl, C 6 -C 20 arylalkyl and C 2 -C 20 heteroaryl.

其他較佳之碳基及烴基團係具有1個至40個、較佳1個至25個C原子之直鏈、具支鏈或環狀烷基,其未經取代或經F、Cl、Br、I或CN單取代或多取代,且其中一或多個不毗鄰CH2基團可以O及/或S原子彼此不直接連接之方式各自彼此獨立地由-C(Rx)=C(Rx)-、-C≡C-、-N(Rx)-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-替代。Other preferred carbon-based and hydrocarbon groups are linear, branched or cyclic alkyl groups having from 1 to 40, preferably from 1 to 25, C atoms which are unsubstituted or substituted by F, Cl, Br, I or CN is mono- or poly-substituted, and one or more of the non-adjacent CH 2 groups may be independently from each other independently by -C(R x )=C(R x ) in such a manner that O and/or S atoms are not directly connected to each other. )-, -C≡C-, -N(R x )-, -O-, -S-, -CO-, -CO-O-, -O-CO-, -O-CO-O-.

Rx較佳表示H、鹵素、具有1個至25個C原子之直鏈、具支鏈或環狀烷基鏈,另外,其中一或多個不毗鄰C原子可由-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-替代,且其中一或多個H原子可由氟替代;具有6個至40個C原子之視情況經取代之芳基或芳基氧基;或具有2個至40個C原子之視情況經取代之雜芳基或雜芳基氧基。R x preferably denotes H, halogen, a linear, branched or cyclic alkyl chain having from 1 to 25 C atoms, and additionally, one or more of the non-adjacent C atoms may be -O-, -S- , -CO-, -CO-O-, -O-CO-, -O-CO-O-, and wherein one or more of the H atoms may be replaced by fluorine; having from 6 to 40 C atoms as appropriate a substituted aryl or aryloxy group; or an optionally substituted heteroaryl or heteroaryloxy group having 2 to 40 C atoms.

較佳之烷氧基係(例如)甲氧基、乙氧基、2-甲氧基乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁氧基、第三丁氧基、2-甲基丁氧基、正戊氧基、正己氧基、正庚氧基、正辛氧基、正壬氧基、正癸氧基、正十一烷氧基、正十二烷氧基等。Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxyethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, second butoxy , third butoxy, 2-methylbutoxy, n-pentyloxy, n-hexyloxy, n-heptyloxy, n-octyloxy, n-decyloxy, n-decyloxy, n-undecyloxy Base, n-dodecyloxy and the like.

較佳之烷基係(例如)甲基、乙基、正丙基、異丙基、正丁基、異丁基、第二丁基、第三丁基、2-甲基丁基、正戊基、第二戊基、環戊基、正己基、環己基、2-乙基己基、正庚基、環庚基、正辛基、環辛基、正壬基、正癸基、正十一烷基、正十二烷基、十二烷基、三氟甲基、全氟正丁基、2,2,2-三氟乙基、全氟辛基、全氟己基等。Preferred alkyl groups are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, t-butyl, t-butyl, 2-methylbutyl, n-pentyl , second amyl, cyclopentyl, n-hexyl, cyclohexyl, 2-ethylhexyl, n-heptyl, cycloheptyl, n-octyl, cyclooctyl, n-decyl, n-decyl, n-undecane Base, n-dodecyl, dodecyl, trifluoromethyl, perfluoro-n-butyl, 2,2,2-trifluoroethyl, perfluorooctyl, perfluorohexyl, and the like.

較佳之烯基係(例如)乙烯基、丙烯基、丁烯基、戊烯基、環戊烯基、己烯基、環己烯基、庚烯基、環庚烯基、辛烯基、環辛烯基等。Preferred alkenyl groups are, for example, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, ring Octenyl and the like.

較佳之炔基係(例如)乙炔基、丙炔基、丁炔基、戊炔基、己炔基、辛炔基等。Preferred alkynyl groups are, for example, ethynyl, propynyl, butynyl, pentynyl, hexynyl, octynyl and the like.

較佳之烷氧基係(例如)甲氧基、乙氧基、2-甲氧基乙氧基、正丙氧基、異丙氧基、正丁氧基、異丁氧基、第二丁氧基、第三丁氧基、2-甲基丁氧基、正戊氧基、正己氧基、正庚氧基、正辛氧基、正壬氧基、正癸氧基、正十一烷氧基、正十二烷氧基等。Preferred alkoxy groups are, for example, methoxy, ethoxy, 2-methoxyethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, second butoxy , third butoxy, 2-methylbutoxy, n-pentyloxy, n-hexyloxy, n-heptyloxy, n-octyloxy, n-decyloxy, n-decyloxy, n-undecyloxy Base, n-dodecyloxy and the like.

較佳之胺基係(例如)二甲基胺基、甲基胺基、甲基苯基胺基、苯基胺基等。Preferred amine groups are, for example, dimethylamino, methylamino, methylphenylamino, phenylamino and the like.

芳基及雜芳基可為單環或多環,即,其可含有一個環(例如,苯基)或兩個或更多個環,其亦可經稠合(例如,萘基)或共價連接(例如,聯苯基),或含有稠合及連接環之組合。雜芳基含有一或多個雜原子、較佳選自O、N、S及Se。The aryl and heteroaryl groups may be monocyclic or polycyclic, that is, they may contain one ring (eg, phenyl) or two or more rings, which may also be fused (eg, naphthyl) or co- Valence linkage (eg, biphenyl), or a combination of fused and linked rings. The heteroaryl group contains one or more heteroatoms, preferably selected from the group consisting of O, N, S and Se.

尤佳者係具有6個至25個C原子之單環、二環或三環芳基、及具有2個至25個C原子之單環、二環或三環雜芳基,其視情況含有稠環且視情況經取代。較佳者進一步係5-、6-或7-員芳基及雜芳基,另外,其中一或多個CH基團可以O原子及/或S原子彼此不直接連接之方式由N、S或O替代。Particularly preferred are monocyclic, bicyclic or tricyclic aryl groups having 6 to 25 C atoms, and monocyclic, bicyclic or tricyclic heteroaryl groups having 2 to 25 C atoms, which are optionally contained A fused ring and replaced as appropriate. Further preferred are 5-, 6- or 7-membered aryl and heteroaryl groups, in addition, one or more of the CH groups may be N, S or may be independently bonded to each other by O atoms and/or S atoms. O replacement.

較佳之芳基係(例如)苯基、聯苯基、聯三苯基、[1,1':3',1"]聯三苯-2'-基、萘基、蒽基、聯萘基、菲基、芘基、二氫芘基、艸屈基、苝基、并四苯基、并五苯基、苯并芘基、茀基、茚基、茚并茀基、螺二環茀基等。Preferred aryl groups are, for example, phenyl, biphenyl, terphenyl, [1,1':3',1"]triphenyl-2'-yl, naphthyl, anthracenyl, binaphthyl , phenanthryl, fluorenyl, indanyl, decyl, fluorenyl, tetraphenyl, pentacene, benzindenyl, anthracenyl, fluorenyl, indenyl, stilbene Wait.

較佳之雜芳基係(例如)5-員環,例如吡咯、吡唑、咪唑、1,2,3-三唑、1,2,4-三唑、四唑、呋喃、噻吩、硒吩、噁唑、異噁唑、1,2-噻唑、1,3-噻唑、1,2,3-噁二唑、1,2,4-噁二唑、1,2,5-噁二唑、1,3,4-噁二唑、1,2,3-噻二唑、1,2,4-噻二唑、1,2,5-噻二唑、1,3,4-噻二唑;6-員環,例如吡啶、嗒嗪、嘧啶、吡嗪、1,3,5-三嗪、1,2,4-三嗪、1,2,3-三嗪、1,2,4,5-四嗪、1,2,3,4-四嗪、1,2,3,5-四嗪;或稠合基團,例如吲哚、異吲哚、吲嗪、吲唑、苯并咪唑、苯并三唑、嘌呤、萘并咪唑、菲并咪唑、吡啶并咪唑、吡嗪并咪唑、喹喏啉并咪唑、苯并噁唑、萘并噁唑、蒽并噁唑、菲并噁唑、異噁唑、苯并噻唑、苯并呋喃、異苯并呋喃、二苯并呋喃、喹啉、異喹啉、蝶啶、苯并-5,6-喹啉、苯并-6,7-喹啉、苯并-7,8-喹啉、苯并異喹啉、吖啶、吩噻嗪、吩噁嗪、苯并嗒嗪、苯并嘧啶、喹喏啉、吩嗪、萘啶、氮雜咔唑、苯并哢啉、菲啶、啡啉、噻吩并[2,3b]噻吩、噻吩并[3,2b]噻吩、二噻吩并噻吩、異苯并噻吩、二苯并噻吩、苯并噻二唑并噻吩、或此等基團之組合。雜芳基亦可經烷基、烷氧基、硫代烷基、氟、氟烷基或其他芳基或雜芳基取代。Preferred heteroaryl groups are, for example, 5-membered rings such as pyrrole, pyrazole, imidazole, 1,2,3-triazole, 1,2,4-triazole, tetrazole, furan, thiophene, selenophene, Oxazole, isoxazole, 1,2-thiazole, 1,3-thiazole, 1,2,3-oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1 , 3,4-oxadiazole, 1,2,3-thiadiazole, 1,2,4-thiadiazole, 1,2,5-thiadiazole, 1,3,4-thiadiazole; - Member rings, such as pyridine, pyridazine, pyrimidine, pyrazine, 1,3,5-triazine, 1,2,4-triazine, 1,2,3-triazine, 1,2,4,5- Tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine; or a condensed group such as anthracene, isoindole, pyridazine, oxazole, benzimidazole, benzene And triazole, anthracene, naphthimidazole, phenamimidazole, pyridoimidazole, pyrazinoimidazole, quinoxalinimidazole, benzoxazole, naphthoxazole, anthraquinone, phenanthroxazole, different Oxazole, benzothiazole, benzofuran, isobenzofuran, dibenzofuran, quinoline, isoquinoline, pteridine, benzo-5,6-quinoline, benzo-6,7-quinoline , benzo-7,8-quinoline, benzoisoquinoline, acridine, phenothiazine, phenoxazine, benzoxazine, benzopyrimidine, quinoxaline, phenazine, Pyridine, azacarbazole, benzoporphyrin, phenanthridine, phenanthroline, thieno[2,3b]thiophene, thieno[3,2b]thiophene, dithienothiophene, isobenzothiophene, dibenzothiophene , benzothiadiazole thiophene, or a combination of such groups. Heteroaryl groups can also be substituted with alkyl, alkoxy, thioalkyl, fluoro, fluoroalkyl or other aryl or heteroaryl groups.

(非芳香族)脂環及雜環基團包括飽和環(即,彼等排他性地含有單鍵者)以及部分不飽和環(即,彼等亦可含有多重鍵者)二者。雜環含有一或多個雜原子,較佳選自Si、O、N、S及Se。(Non-aromatic) alicyclic and heterocyclic groups include both saturated rings (ie, those which exclusively contain a single bond) and partially unsaturated rings (ie, those which may also contain multiple bonds). The heterocycle contains one or more heteroatoms, preferably selected from the group consisting of Si, O, N, S and Se.

(非芳香族)脂環及雜環基團可為單環(即,僅含有一個環(例如,環己烷))或多環(即,含有複數個環(例如,十氫化萘或二環辛烷))。尤佳者係飽和基團。較佳者進一步係具有3個至25個C原子之單環、二環或三環基團,其視情況含有稠環且視情況經取代。較佳者進一步係5-、6-、7-或8-員碳環基團,另外,其中一或多個C原子可由Si替代及/或一或多個CH基團可由N替代及/或一或多個不毗鄰CH2基團可由-O-及/或-S-替代。The (non-aromatic) alicyclic and heterocyclic groups may be monocyclic (ie, containing only one ring (eg, cyclohexane)) or polycyclic (ie, containing a plurality of rings (eg, decalin or bicyclic) Octane)). Particularly preferred are saturated groups. Preferred are further monocyclic, bicyclic or tricyclic groups having from 3 to 25 C atoms, optionally containing a fused ring and optionally substituted. More preferably a 5-, 6-, 7- or 8-membered carbocyclic group, in which one or more C atoms may be replaced by Si and/or one or more CH groups may be replaced by N and/or One or more non-adjacent CH 2 groups may be replaced by -O- and/or -S-.

較佳之脂環及雜環基團係(例如)5-員基團,例如環戊烷、四氫呋喃、四氫噻吩、吡咯啶;6-員基團,例如環己烷、環己烯、四氫哌喃、四氫硫哌喃、1,3-二噁烷、1,3-二噻烷、六氫吡啶;7-員基團,例如環庚烷;及稠合基團,例如四氫化萘、十氫化萘、二氫茚、二環[1.1.1]戊烷-1,3-二基、二環[2.2.2]辛烷-1,4-二基、螺[3.3]庚烷-2,6-二基、八氫-4,7-亞甲基二氫茚-2,5-二基。Preferred alicyclic and heterocyclic groups are, for example, 5-membered groups such as cyclopentane, tetrahydrofuran, tetrahydrothiophene, pyrrolidine; 6-member groups such as cyclohexane, cyclohexene, tetrahydrogen Piperane, tetrahydrothiopyran, 1,3-dioxane, 1,3-dithiane, hexahydropyridine; a 7-member group such as cycloheptane; and a condensed group such as tetralin , decalin, indoline, bicyclo[1.1.1]pentane-1,3-diyl, bicyclo[2.2.2]octane-1,4-diyl, spiro[3.3]heptane- 2,6-Diyl, octahydro-4,7-methyleneindoline-2,5-diyl.

較佳取代基係(例如)促進溶解之基團(例如烷基或烷氧基)、吸電子基團(例如,氟、硝基或腈)、或用於增加聚合物玻璃化轉變溫度(Tg)的基團,具體而言龐大基團(例如,第三丁基或視情況經取代之芳基)。Preferred substituents are, for example, groups which promote dissolution (for example alkyl or alkoxy groups), electron withdrawing groups (for example, fluorine, nitro or nitriles), or for increasing the glass transition temperature of polymers (Tg) a group, in particular a bulky group (for example, a tert-butyl group or an optionally substituted aryl group).

較佳之取代基(上文及下文中亦稱為"L")係(例如)F、Cl、Br、I、-CN、-NO2、-NCO、-NCS、-OCN、-SCN、-C(=O)N(Rx)2、-C(=O)Y1、-C(=O)Rx、-N(Rx)2,其中Rx具有上文所指出之含義,且Y1表示鹵素、視情況經取代之甲矽烷基或具有6個至40個、較佳6個至20個C原子之芳基、及具有1個至25個C原子之直鏈或具支鏈烷基、烷氧基、烷基羰基、烷氧基羰基、烷基羰基氧基或烷氧基羰基氧基,其中一或多個H原子可視情況由F或Cl替代。Preferred substituents (also referred to above as "L") are, for example, F, Cl, Br, I, -CN, -NO 2 , -NCO, -NCS, -OCN, -SCN, -C (=O)N(R x ) 2 , -C(=O)Y 1 , -C(=O)R x , -N(R x ) 2 , where R x has the meaning indicated above, and Y 1 represents a halogen, optionally substituted methylidene or an aryl group having 6 to 40, preferably 6 to 20 C atoms, and a linear or branched alkane having 1 to 25 C atoms. Alkyl, alkoxy, alkylcarbonyl, alkoxycarbonyl, alkylcarbonyloxy or alkoxycarbonyloxy, wherein one or more H atoms may be replaced by F or Cl, as appropriate.

「經取代之甲矽烷基或芳基」較佳意指經鹵素、-CN、R0、-OR0、-CO-R0、-CO-O-R0、-O-CO-R0或-O-CO-O-R0取代,其中R0具有上文所指出之含義。"Substituted carboxyalkyl or aryl" preferably means halogen, -CN, R 0 , -OR 0 , -CO-R 0 , -CO-OR 0 , -O-CO-R 0 or -O. -CO-OR 0 substitution, wherein R 0 has the meaning indicated above.

尤佳之取代基L係(例如)F、Cl、CN、NO2、CH3、C2H5、OCH3、OC2H5、COCH3、COC2H5、COOCH3、COOC2H5、CF3、OCF3、OCHF2、OC2F5,進一步係苯基。較佳為其中L具有上文所指出之含義中之一者。Further preferred substituents L are, for example, F, Cl, CN, NO 2 , CH 3 , C 2 H 5 , OCH 3 , OC 2 H 5 , COCH 3 , COC 2 H 5 , COOCH 3 , COOC 2 H 5 , CF 3 , OCF 3 , OCHF 2 , OC 2 F 5 , further a phenyl group. Preferred or Where L has one of the meanings indicated above.

可聚性基團P係適於聚合反應(例如自由基或離子鏈聚合、加聚或縮聚)或適於聚合物類似物反應(例如加成或縮合至聚合物主鏈上)之基團。尤佳者係用於鏈聚合之基團(具體而言彼等含有C=C雙鍵或C≡C三鍵者)、及適於開環聚合之基團(例如,環氧丙烷或環氧化物基團)。The polymerizable group P is suitable for polymerization (for example, radical or ionic chain polymerization, addition polymerization or polycondensation) or a group suitable for the reaction of a polymer analog (for example, addition or condensation onto the polymer backbone). Particularly preferred are groups for chain polymerization (specifically, those containing C=C double bonds or C≡C triple bonds), and groups suitable for ring opening polymerization (for example, propylene oxide or epoxy) Compound group).

較佳之基團P係如上文針對式I所定義。Preferred groups P are as defined above for Formula I.

較佳之間隔基團Sp選自式Sp'-X-,其如上文針對式I所闡述。Preferably, the spacer group Sp is selected from the group consisting of the formula Sp'-X- as set forth above for Formula I.

在本發明之又一較佳實施例中,P-Sp-表示含有兩個或更多個可聚性基團之基團(多官能可聚性基團)。此類型之適宜基團、及含有其之可聚性化合物及其製備闡述於(例如)US 7,060,200 B1或US 2006/0172090 A1中。尤佳者選自以下各式之多官能可聚性基團P-Sp-:In still another preferred embodiment of the present invention, P-Sp- represents a group (polyfunctional polymerizable group) containing two or more polymerizable groups. Suitable groups of this type, and polymerizable compounds containing the same, and their preparation are described, for example, in US 7,060,200 B1 or US 2006/0172090 A1. Particularly preferred are selected from the following polyfunctional polymerizable groups P-Sp-:

-X-烷基-CHP1-CH2-CH2P2 I*a-X-alkyl-CHP 1 -CH 2 -CH 2 P 2 I*a

-X-烷基-C(CH2P1)(CH2P2)-CH2P3 I*b-X-alkyl-C(CH 2 P 1 )(CH 2 P 2 )-CH 2 P 3 I*b

-X-烷基-CHP1CHP2-CH2P3 I*c-X-alkyl-CHP 1 CHP 2 -CH 2 P 3 I*c

-X-烷基-C(CH2P1)(CH2P2)-CaaH2aa+1 I*d-X-alkyl-C(CH 2 P 1 )(CH 2 P 2 )-C aa H 2aa+1 I*d

-X-烷基-CHP1-CH2P2 I*e-X-alkyl-CHP 1 -CH 2 P 2 I*e

-X-烷基-CHP1P2 I*f-X-alkyl-CHP 1 P 2 I*f

-X-烷基-CP1P2-CaaH2aa+1 I*g-X-alkyl-CP 1 P 2 -C aa H 2aa+1 I*g

-X-烷基-C(CH2P1)(CH2P2)-CH2OCH2-C(CH2P3)(CH2P4)CH2P5 I*h-X-Alkyl-C(CH 2 P 1 )(CH 2 P 2 )-CH 2 OCH 2 -C(CH 2 P 3 )(CH 2 P 4 )CH 2 P 5 I*h

-X-烷基-CH((CH2)aaP1)((CH2)bbP2) I*i-X-alkyl-CH((CH 2 ) aa P 1 )((CH 2 ) bb P 2 ) I*i

-X-烷基-CHP1CHP2-CaaH2aa+1 I*k-X-alkyl-CHP 1 CHP 2 -C aa H 2aa+1 I*k

-X-烷基-C(CH3)(CH2P1)(CH2P2) I*m-X-alkyl-C(CH 3 )(CH 2 P 1 )(CH 2 P 2 ) I*m

其中烷基 表示單鍵或具有1個至12個C原子之直鏈或具支鏈伸烷基,其中一或多個不毗鄰CH2基團可以O及/或S原子不直接彼此連接之方式各自彼此獨立地由-C(R00)=C(R000)-、-C≡C-、-N(R00)-、-O-、-S-、-CO-、-CO-O-、-O-CO-、-O-CO-O-替代,且另外,其中一或多個H原子可由F、Cl或CN替代,其中R00及R000具有上文所指出含義,aa及bb各自彼此獨立地表示0、1、2、3、4、5或6,且P1-5 各自彼此獨立地具有對P所指出含義中之一者。Wherein alkyl represents a single bond or a straight or branched alkyl group having from 1 to 12 C atoms, wherein one or more of the non-adjacent CH 2 groups may be such that O and/or S atoms are not directly bonded to each other. Each independently of -C(R 00 )=C(R 000 )-, -C≡C-, -N(R 00 )-, -O-, -S-, -CO-, -CO-O- , -O-CO-, -O-CO-O- is substituted, and additionally, one or more of the H atoms may be replaced by F, Cl or CN, wherein R 00 and R 000 have the meanings indicated above, aa and bb Each independently represents 0, 1 , 2, 3, 4, 5 or 6, and P 1-5 each have one of the meanings indicated for P independently of each other.

可聚性化合物及RM可以與熟習此項技術之人員所習知方法類似之方式製備且闡述於有機化學標準著作中,例如Houben-Weyl,Methoden der organischen Chemie[Methods of Organic Chemistry],Thieme-Verlag,Stuttgart中。其他合成方法在上文及下文所引用之文件中給出。在最簡單情形下,此類RM係(例如)藉由在脫水試劑(例如,DCC(二環己基碳二亞胺))存在下使用含有基團P之相應酸、酸衍生物或鹵代化合物(例如(甲基)丙烯醯氯或(甲基)丙烯酸)酯化或醚化2,6-二羥基萘或4,4'-二羥基聯苯來合成。The polymerizable compound and RM can be prepared in a manner similar to that known to those skilled in the art and described in standard work on organic chemistry, such as Houben-Weyl, Methoden der organischen Chemie [Methods of Organic Chemistry], Thieme-Verlag , Stuttgart. Other synthetic methods are given in the documents cited above and below. In the simplest case, such RM is used, for example, by the use of a corresponding acid, acid derivative or halogenated compound containing a group P in the presence of a dehydrating reagent such as DCC (dicyclohexylcarbodiimide). (for example, (meth)acrylofluorene or (meth)acrylic acid) esterified or etherified 2,6-dihydroxynaphthalene or 4,4'-dihydroxybiphenyl to be synthesized.

作為又一組份,液晶介質較佳包含支撐液晶相之非可聚性化合物,其亦稱為主體混合物。其比例通常為50重量%至95重量%,較佳為80重量%至90重量%。在經聚合物穩定之藍相之情形下,非可聚性部分較佳包含選自表A之化合物(參見實例部分)。該部分較佳由50重量%或更多的此等化合物組成,極佳80重量%或更多。As a further component, the liquid crystal medium preferably comprises a non-polymerizable compound which supports the liquid crystal phase, which is also referred to as a host mixture. The proportion is usually from 50% by weight to 95% by weight, preferably from 80% by weight to 90% by weight. In the case of a polymer-stabilized blue phase, the non-polymerizable moiety preferably comprises a compound selected from Table A (see the Examples section). This portion preferably consists of 50% by weight or more of these compounds, and is preferably 80% by weight or more.

本發明具有藍相之液晶介質較佳具有正介電各向異性。其可以具有極高介電各向異性與高光學各向異性值之方式構造。The liquid crystal medium having a blue phase of the present invention preferably has positive dielectric anisotropy. It can be constructed in such a manner as to have extremely high dielectric anisotropy and high optical anisotropy values.

本發明用於液晶介質之其他較佳化合物選自式II及III之化合物:Other preferred compounds of the invention for liquid crystal media are selected from the group consisting of the compounds of formula II and III:

其中R1 在每一情形下彼此獨立地表示具有1個至15個C原子之未經取代之烷基,另外,其中此基團中之一或多個CH2基團可以O原子彼此不直接連接之方式各自彼此獨立地由-C≡C-、-CH=CH-、-CF=CF-、-CF=CH-、-CH=CF-、-(CO)O-、-O(CO)-、-(CO)-或-O-替代,較佳為具有2個至7個C原子之直鏈烷基,A2、A3彼此獨立地表示Wherein R 1 independently of each other represents an unsubstituted alkyl group having from 1 to 15 C atoms, and wherein one or more of the CH 2 groups in the group may not directly be mutually O atoms The manner of connection is independent of each other by -C≡C-, -CH=CH-, -CF=CF-, -CF=CH-, -CH=CF-, -(CO)O-, -O(CO) -, -(CO)- or -O-, preferably a linear alkyl group having 2 to 7 C atoms, and A 2 and A 3 are independently represented

Z2、Z3彼此獨立地表示單鍵、CF2O、CH2CH2、CF2CH2、CF2CF2、CFHCFH、CFHCH2、(CO)O、CH2O、C=C、CH=CH、CF=CH、CF=CF,其中不對稱連接成員(例如CF2O)可在兩個可能方向上定向,X1 表示F、Cl、CN、或具有1個至3個C原子之烷基、烯基、烯基氧基、烷基烷氧基或烷氧基,其經F單取代或多取代,且L1至L4表示H或F。Z 2 and Z 3 independently of each other represent a single bond, CF 2 O, CH 2 CH 2 , CF 2 CH 2 , CF 2 CF 2 , CFHCFH, CFHCH 2 , (CO)O, CH 2 O, C=C, CH =CH, CF=CH, CF=CF, wherein an asymmetric linking member (eg CF 2 O) can be oriented in two possible directions, X 1 representing F, Cl, CN, or having 1 to 3 C atoms An alkyl group, an alkenyl group, an alkenyloxy group, an alkyl alkoxy group or an alkoxy group which is mono- or polysubstituted by F, and L 1 to L 4 represents H or F.

液晶介質較佳包含介於20重量%與40重量%之間的式II化合物。若存在式III化合物,則其較佳以最高20重量%使用。若存在其餘其他化合物,則其選自其他具有高介電各向異性、高光學各向異性且較佳具有高澄清點之化合物。The liquid crystal medium preferably comprises between 20% and 40% by weight of a compound of formula II. If a compound of formula III is present, it is preferably used up to 20% by weight. If other compounds are present, they are selected from other compounds having high dielectric anisotropy, high optical anisotropy and preferably having a high clearing point.

較佳之式II化合物係彼等具有式IIa者:Preferred compounds of formula II are those of formula IIa:

其中R1及L1係如對式II所定義。Wherein R 1 and L 1 are as defined for formula II.

較佳之式III化合物係彼等具有式IIIa或IIIb者:Preferred compounds of formula III are those of formula IIIa or IIIb:

其中R1係如對式III所定義。Wherein R 1 is as defined for formula III.

可根據本發明使用之LC介質係以本身已為吾人習知之方式來製備,例如藉將一或多種上文提及化合物與一或多種如上文所定義之可聚性化合物、且視情況與其他液晶化合物及/或添加劑混合。一般而言,有利地在高溫下將期望量的用量較小的組份溶於構成主要部分之組份中。亦可能在有機溶劑中混合該等組份之溶液,例如在丙酮、氯仿或甲醇中,且在充分混合後再藉由(例如)蒸餾來去除溶劑。本發明進一步係關於製備本發明LC介質之方法。LC media which can be used in accordance with the invention are prepared in a manner which is customary per se, for example by the addition of one or more of the above-mentioned compounds with one or more polymerizable compounds as defined above, and optionally The liquid crystal compound and/or the additive are mixed. In general, it is advantageous to dissolve a desired amount of the component in a small amount in a component constituting the main portion at a high temperature. It is also possible to mix solutions of the components in an organic solvent, for example in acetone, chloroform or methanol, and after thorough mixing, remove the solvent by, for example, distillation. The invention further relates to a process for preparing an LC medium of the invention.

對熟習此項技術者不言而喻的是,本發明LC介質亦可包含其中(例如)H、N、O、Cl、F已由相應同位素替代之化合物。It will be apparent to those skilled in the art that the LC media of the present invention may also comprise compounds in which, for example, H, N, O, Cl, F have been replaced by the corresponding isotopes.

出於本發明之目的,術語烷基、烯基等定義如下:術語「烷基」涵蓋具有1個至9個碳原子之直鏈及具支鏈烷基,具體而言直鏈基團甲基、乙基、丙基、丁基、戊基、己基及庚基。具有2-5個碳原子之基團通常較佳。For the purposes of the present invention, the terms alkyl, alkenyl and the like are defined as follows: The term "alkyl" embraces straight-chain and branched alkyl groups having from 1 to 9 carbon atoms, in particular straight-chain methyl groups. , ethyl, propyl, butyl, pentyl, hexyl and heptyl. A group having 2 to 5 carbon atoms is usually preferred.

術語「烯基」涵蓋具有最多9個碳原子之直鏈及具支鏈烯基,具體而言直鏈基團。尤佳之烯基係C2-C7-1E-烯基、C4-C7-3E-烯基、C5-C7-4-烯基、C6-C7-5-烯基及C7-6-烯基,具體而言C2-C7-1E-烯基、C4-C7-3E-烯基及C5-C7-4-烯基。較佳烯基之實例係乙烯基、1E-丙烯基、1E-丁烯基、1E-戊烯基、1E-己烯基、1E-庚烯基、3-丁烯基、3E-戊烯基、3E-己烯基、3E-庚烯基、4-戊烯基、4Z-己烯基、4E-己烯基、4Z-庚烯基、5-己烯基、6-庚烯基及諸如此類。具有最多5個碳原子之基團通常較佳。The term "alkenyl" encompasses straight-chain and branched alkenyl groups having up to 9 carbon atoms, in particular straight-chain groups. More preferably, the alkenyl group is a C 2 -C 7 -1E-alkenyl group, a C 4 -C 7 -3E-alkenyl group, a C 5 -C 7 -4-alkenyl group, a C 6 -C 7 -5-alkenyl group, and C 7 -6-alkenyl, in particular C 2 -C 7 -1E-alkenyl, C 4 -C 7 -3E-alkenyl and C 5 -C 7 --4-alkenyl. Examples of preferred alkenyl groups are ethenyl, 1E-propenyl, 1E-butenyl, 1E-pentenyl, 1E-hexenyl, 1E-heptenyl, 3-butenyl, 3E-pentenyl 3E-hexenyl, 3E-heptenyl, 4-pentenyl, 4Z-hexenyl, 4E-hexenyl, 4Z-heptenyl, 5-hexenyl, 6-heptenyl and the like . Groups having up to 5 carbon atoms are generally preferred.

在本申請案中術語「氟烷基」涵蓋含有至少一個氟原子(較佳末端氟)之直鏈基團,即氟甲基、2-氟乙基、3-氟丙基、4-氟丁基、5-氟戊基、6-氟己基及7-氟庚基。然而,氟之其他位置並未排除在外。The term "fluoroalkyl" as used in this application encompasses a straight-chain group containing at least one fluorine atom (preferably terminal fluorine), namely fluoromethyl, 2-fluoroethyl, 3-fluoropropyl, 4-fluorobutyl. Base, 5-fluoropentyl, 6-fluorohexyl and 7-fluoroheptyl. However, other locations of fluorine are not excluded.

術語「鹵代烷基」較佳涵蓋單-或多氟化及/或氯化基團。包括全氟化基團。尤佳者係氟化烷基,具體而言CF3、CH2CF3、CH2CHF2、CHF2、CH2F、CHFCF3及CF2CHFCF3The term "haloalkyl" preferably encompasses mono- or polyfluorinated and/or chlorinated groups. Includes perfluorinated groups. More preferred are fluorinated alkyl groups, specifically CF 3 , CH 2 CF 3 , CH 2 CHF 2 , CHF 2 , CH 2 F, CHFCF 3 and CF 2 CHFCF 3 .

術語「伸烷基」涵蓋具有1個至12個碳原子之直鏈及具支鏈烷二基,具體而言直鏈基團亞甲基、伸乙基、伸丙基、伸丁基及伸戊基。具有2個至8個碳原子之基團通常較佳。The term "alkylene" encompasses straight-chain and branched alkanediyl groups having from 1 to 12 carbon atoms, in particular straight-chain groups methylene, ethyl, propyl, butyl and extens Amyl. Groups having 2 to 8 carbon atoms are generally preferred.

根據說明亦可自申請專利範圍產生本發明實施例及變化形式之其他組合。Other combinations of embodiments and variations of the invention may be derived from the scope of the invention as claimed.

所用縮寫:DCC 二環已基碳二亞胺,DMAP 4-(二甲基胺基)吡啶,9-BBN 9-硼二環[3.3.1]壬烷,MTBE 甲基第三丁基醚,DMSO 二甲基亞碸。Abbreviations used: DCC bicyclohexylcarbodiimide, DMAP 4-(dimethylamino)pyridine, 9-BBN 9-borobicyclo[3.3.1]decane, MTBE methyl tert-butyl ether, DMSO dimethyl hydrazine.

各相代號:C:結晶;N:向列型;BP:藍相;Tg:玻璃態轉變溫度;I:各向同性。Each phase code: C: crystal; N: nematic; BP: blue phase; Tg: glass transition temperature; I: isotropic.

實例Instance 實例1:5-(2-甲基丙烯醯基氧基)戊酸(3R,4S,5R)-4,5,6-叁-[5-(2-甲基丙烯醯基氧基)戊醯基氧基]四氫哌喃-3-基酯Example 1: 5-(2-Methylpropenylmethoxy)pentanoic acid (3R,4S,5R)-4,5,6-indole-[5-(2-methylpropenyloxy)pentanyl Vinyl]tetrahydropyran-3-yl ester

本發明化合物5-(2-甲基丙烯醯基氧基)戊酸(3R,4S,5R)-4,5,6-叁-[5-(2-甲基丙烯醯基氧基)戊醯基氧基]四氫哌喃-3-基酯係如下文所述合成。The compound of the present invention 5-(2-methylpropenyloxy)pentanoic acid (3R,4S,5R)-4,5,6-indole-[5-(2-methylpropenyloxy)pentanyl The benzyloxy]tetrahydropyran-3-yl ester was synthesized as described below.

1.1使用溴戊酸酯化D-(+)-木糖:5-溴戊酸(3R,4S,5R)-4,5,6-叁-(5-溴戊醯基氧基)四氫哌喃-3-基酯之製備1.1 Use of bromopentanoate to D-(+)-xylose: 5-bromopentanoic acid (3R,4S,5R)-4,5,6-indole-(5-bromopentenyloxy)tetrahydroperoxide Preparation of m--3-yl ester

首先將20.0 g(0.13 mol) D-(+)-木糖與120.0 g(0.67 mol) 5-溴戊酸及1.0 g(8.19 mmol) DMAP一起引入1500 ml二氯甲烷中。計量加入140.0 g(0.68 mol) DCC於500 ml二氯甲烷中之溶液,並在室溫下將混合物攪拌72 h。添加50.0 g(0.40 mol)二水草酸,並在1 h後濾出不溶物質。將濾液濃縮至乾燥,並藉由管柱層析(SiO2、二氯甲烷:MTBE=97:3)來純化殘餘物。First, 20.0 g (0.13 mol) of D-(+)-xylose was introduced into 1500 ml of dichloromethane together with 120.0 g (0.67 mol) of 5-bromopentanoic acid and 1.0 g (8.19 mmol) of DMAP. A solution of 140.0 g (0.68 mol) DCC in 500 ml of dichloromethane was added and the mixture was stirred at room temperature for 72 h. 50.0 g (0.40 mol) of oxalic acid was added, and after 1 h, the insoluble matter was filtered off. The filtrate was concentrated to dryness and purified by column chromatography on the residue (SiO 2, dichloromethane: 3: MTBE = 97).

1.2 5-(2-甲基丙烯醯基氧基)戊酸(3R,4S,5R)-4,5,6-叁-[5-(2-甲基丙烯醯基氧基)戊醯基氧基]四氫哌喃-3-基酯之製備1.2 5-(2-Methylacryloyloxy)pentanoic acid (3R,4S,5R)-4,5,6-indole-[5-(2-methylpropenyloxy)pentenyloxy Preparation of tetrahydropyran-3-yl ester

在50℃下在50 ml DMSO中將3.5 g(4.36 mmol) 5-溴戊酸(3R,4S,5R)-4,5,6-叁-(5-溴戊醯基氧基)四氫哌喃-3-基酯與4.4 ml(52.0 mmol)甲基丙烯酸及8.44 g(61.1 mmol)碳酸鉀一起攪拌。將懸浮液用MTBE稀釋並用水洗滌。用MTBE萃取水相,並用飽和氯化鈉溶液洗滌合併的有機相。使用硫酸鈉乾燥溶液並濃縮至乾燥。藉由管柱層析(SiO2,二氯甲烷:MTBE=95:5)來純化殘餘物,得到無色油狀5-(2-甲基丙烯醯基氧基)戊酸(3R,4S,5R)-4,5,6-叁-[5-(2-甲基丙烯醯基氧基)戊醯基氧基]四氫哌喃-3-基酯(α:β88:12)。3.5 g (4.36 mmol) of 5-bromopentanoic acid (3R,4S,5R)-4,5,6-indole-(5-bromopentenyloxy)tetrahydropyridinium in 50 ml of DMSO at 50 °C The m--3-yl ester was stirred with 4.4 ml (52.0 mmol) of methacrylic acid and 8.44 g (61.1 mmol) of potassium carbonate. The suspension was diluted with MTBE and washed with water. The aqueous phase was extracted with MTBE and the combined organic phases were washed with saturated sodium chloride. The solution was dried over sodium sulfate and concentrated to dryness. By column chromatography (SiO 2, dichloromethane: MTBE = 95: 5) and the residue was purified to give a colorless oil of 5- (2-Bing Xixi yloxy) valeric acid (3R, 4S, 5R -4,5,6-indole-[5-(2-methylpropenyloxy)pentenyloxy]tetrahydropyran-3-yl ester (α:β 88:12).

相序:Tg-62 IPhase sequence: Tg-62 I

1 H-NMR(300 MHz,CHCl3):δ=6.29(d,1H,J=3.7 Hz,H哌喃基),6.11-6.07(m,4H,H丙烯酸酯),5.57-5.54(m,4H,H丙烯酸酯),5.47(t,1H,J=9.8 Hz,H哌喃基),5.10-5.02(m,2H,H哌喃基),4.20-4.10(m,8 H,4×CH 2 OC(O)),3.94(dd,1H,J=11.3 Hz,J=5.9 Hz,H哌喃基),3.69(t,1H,J=11.3 Hz,H哌喃基),2.52-2.23(m,8H,4×OC(O)CH 2 ),1.95-1.93(m,12H,4×CMe=CH2),1.79-1.63(m,16H,H脂肪族)。 1 H-NMR (300 MHz, CHCl 3 ): δ = 6.29 (d, 1H, J = 3.7 Hz, H - pyranyl), 6.11-6.07 (m, 4H, H acrylate ), 5.57-5.54 (m, 4H, H acrylate ), 5.47 (t, 1H, J = 9.8 Hz, H - pyranyl), 5.10-5.02 (m, 2H, H - pyranyl), 4.20 - 4.10 (m, 8 H, 4 x CH 2 OC(O)), 3.94 (dd, 1H, J = 11.3 Hz, J = 5.9 Hz, H -pyranyl ), 3.69 (t, 1H, J = 11.3 Hz, H - pyranyl), 2.52-2.23 ( m, 8H, 4 x OC(O) CH 2 ), 1.95-1.93 (m, 12H, 4 x C Me = CH 2 ), 1.79-1.63 (m, 16H, H aliphatic ).

(所指出之數據係針對主要端基異構體)(The data indicated is for the major anomers)

MS(EI):m/e(%)=822(1,M+),69(100)。 MS (EI) : m/e (%) = 822 (1, M + ), 69 (100).

實例2:5-丙烯醯基氧基戊酸(3R,4S,5R)-4,5,6-叁-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯Example 2: 5-Phenyl decyloxypentanoic acid (3R,4S,5R)-4,5,6-indole-(5-propenylfluorenylpentyloxy)tetrahydropyran-3-yl ester

本發明化合物5-丙烯醯基氧基戊酸(3R,4S,5R)-4,5,6-叁-(5-丙烯醯基氧基-戊醯基氧基)四氫哌喃-3-基酯係如下文所述合成。The present invention is a compound 5-propenyl methoxy valeric acid (3R, 4S, 5R)-4,5,6-indole-(5-propenyl methoxy-pentenyloxy)tetrahydropyran-3- The base ester is synthesized as described below.

2.1 5-丙烯醯基氧基戊酸(3R,4S,5R)-4,5,6-叁-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯之製備2.1 5-Acryl-mercaptooxyvaleric acid (3R,4S,5R)-4,5,6-indole-(5-propenyloxypentenyloxy)tetrahydropyran-3-yl ester preparation

在50℃下在500 ml DMSO中將17.0 g(17.3 mmol) 5-溴戊酸(3R,4S,5R)-4,5,6-叁-(5-溴戊醯基氧基)四氫哌喃-3-基酯與14.3 ml(0.21 mol)丙烯酸及33.5 g(0.24 mol)碳酸鉀一起攪拌。將懸浮液用MTBE稀釋並用水洗滌。用MTBE萃取水相,並用飽和氯化鈉溶液洗滌合併的有機相。使用硫酸鈉乾燥溶液並濃縮至乾燥。藉由管柱層析(SiO2,二氯甲烷:MTBE=95:5及SiO2,戊烷:MTBE=6:4)來純化殘餘物,得到無色油狀5-丙烯醯基氧基戊酸(3R,4S,5R)-4,5,6-叁-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯(a:β92:8)。17.0 g (17.3 mmol) of 5-bromopentanoic acid (3R,4S,5R)-4,5,6-indole-(5-bromopentenyloxy)tetrahydropyridinium in 500 ml of DMSO at 50 °C The m--3-yl ester was stirred with 14.3 ml (0.21 mol) of acrylic acid and 33.5 g (0.24 mol) of potassium carbonate. The suspension was diluted with MTBE and washed with water. The aqueous phase was extracted with MTBE and the combined organic phases were washed with saturated sodium chloride. The solution was dried over sodium sulfate and concentrated to dryness. By column chromatography (SiO 2, dichloromethane: MTBE = 95: 5 and SiO 2, pentane: MTBE = 6: 4) The residue was purified to give a colorless oil Bing Xixi 5- yloxy acid (3R,4S,5R)-4,5,6-indole-(5-propenyloxypentenyloxy)tetrahydropyran-3-yl ester (a: β 92:8).

相序:Tg-57 IPhase sequence: Tg-57 I

1 H-NMR(300 MHz,CHCl3):δ=6.40(dm,4H,J=17.4 Hz,H丙烯酸酯),6.29(d,1H,J=3.8 Hz,H哌喃基),6.17-6.06(m,4H,H丙烯酸酯),5.83(dm,4H,J=10.4Hz,H丙烯酸酯),5.47(t,1H,J=9.8 Hz,H哌喃基),5.10-5.00(m,2H,H哌喃基),4.22-4.10(m,8 H,4×CH 2 OC(O)),3.94(dd,1H,J=11.3 Hz,J=5.9 Hz,H哌喃基),3.70(t,1H,J=11.3 Hz,H哌喃基),2.52-2.24(m,8H,4×OC(O)CH 2 ),1.79-1.63(m,16H,H脂肪族)。 1 H-NMR (300 MHz, CHCl 3 ): δ = 6.40 (dm, 4H, J = 17.4 Hz, H acrylate ), 6.29 (d, 1H, J = 3.8 Hz, H -pyranyl ), 6.17-6.06 (m, 4H, H acrylate ), 5.83 (dm, 4H, J = 10.4 Hz, H acrylate ), 5.47 (t, 1H, J = 9.8 Hz, H -pyranyl ), 5.10-5.00 (m, 2H) , H -pyranyl ), 4.22-4.10 (m, 8 H, 4 × CH 2 OC(O)), 3.94 (dd, 1H, J = 11.3 Hz, J = 5.9 Hz, H -pyranyl ), 3.70 ( t, 1H, J = 11.3 Hz, H - pyranyl), 2.52-2.24 (m, 8H, 4 x OC(O) CH 2 ), 1.79-1.63 (m, 16H, H aliphatic ).

(所指出之數據係針對主要端基異構體)(The data indicated is for the major anomers)

實例3:5-丙烯醯基氧基戊酸(3R,4S)-4,6-雙-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯Example 3: 5-(Phenylmercaptooxypentanoic acid (3R,4S)-4,6-bis-(5-propenylfluorenylpentyloxy)tetrahydropyran-3-yl ester

本發明化合物5-丙烯醯基氧基戊酸(3R,4S)-4,6-雙-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯係如下文所述合成。The compound of the present invention 5-propenyl methoxy valeric acid (3R, 4S)-4,6-bis-(5-propenyl fluorenylpentenyloxy) tetrahydropyran-3-yl ester is as follows The synthesis.

3.1使用溴戊酸酯化2-脫氧-D-核糖:5-溴戊酸(3R,4S)-4,6-雙-(5-溴戊醯基氧基)四氫哌喃-3-基酯之製備3.1 Use of bromopentanoate to decolorize 2-deoxy-D-ribose: 5-bromopentanoic acid (3R,4S)-4,6-bis-(5-bromopentenyloxy)tetrahydropyran-3-yl Preparation of ester

首先將15.0 g(0.11 mol) 2-脫氧-D-核糖與80.0 g(0.44 mol) 5-溴戊酸及1.0 g(8.19 mmol) DMAP一起引入2000 ml二氯甲烷中。計量加入100.0 g(0.48 mol) DCC於500 ml二氯甲烷中之溶液,並在室溫下將混合物攪拌48 h。再添加20.0 g(0.11 mol) 5-溴戊酸,並再次將混合物攪拌72 h。添加50.0 g(0.40 mol)二水草酸,並在1 h後濾出不溶物質。將濾液濃縮至乾燥,並藉由管柱層析(SiO2,二氯甲烷:MTBE=97:3及Al2O3,二氯甲烷:MTBE=97:3)來純化殘餘物,得到無色油狀5-溴戊酸(3R,4S)-4,6-雙-(5-溴戊醯基氧基)四氫哌喃-3-基酯。First, 15.0 g (0.11 mol) of 2-deoxy-D-ribose was introduced into 2000 ml of dichloromethane together with 80.0 g (0.44 mol) of 5-bromopentanoic acid and 1.0 g (8.19 mmol) of DMAP. A solution of 100.0 g (0.48 mol) DCC in 500 ml of dichloromethane was added and the mixture was stirred at room temperature for 48 h. An additional 20.0 g (0.11 mol) of 5-bromopentanoic acid was added and the mixture was stirred again for 72 h. 50.0 g (0.40 mol) of oxalic acid was added, and after 1 h, the insoluble matter was filtered off. The filtrate was concentrated to dryness and by column chromatography (SiO 2, dichloromethane: MTBE = 97: 3 and Al 2 O 3, dichloromethane: MTBE = 97: 3) and the residue was purified to give a colorless oil (5R,4S)-4,6-bis-(5-bromopentenyloxy)tetrahydropyran-3-yl ester of 5-bromopentanoic acid.

3.2 5-丙烯醯基氧基戊酸(3R,4S)-4,6-雙-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯之製備3.2 Preparation of 5-propenyldecyloxypentanoic acid (3R,4S)-4,6-bis-(5-propenylfluorenylpentyloxy)tetrahydropyran-3-yl ester

在50℃下在500 ml DMSO中將15.0 g(24.1 mmol) 5-丙烯醯基氧基戊酸(3R,4S)-4,6-雙-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯與15.0 ml(0.22 mol)丙烯酸及37.0 g(0.27 mol)碳酸鉀一起攪拌24 h。將懸浮液用MTBE稀釋並用水洗滌。用MTBE萃取水相,並用飽和氯化鈉溶液洗滌合併的有機相。使用硫酸鈉乾燥溶液並濃縮至乾燥。藉由管柱層析來純化殘餘物(SiO2/Al2O3,二氯甲烷:MTBE=95:5及SiO2,二氯甲烷:MTBE=9:1),得到無色油狀5-丙烯醯基氧基戊酸(3R,4S)-4,6-雙-(5-丙烯醯基氧基戊醯基氧基)四氫哌喃-3-基酯(α:β99:1)。15.0 g (24.1 mmol) of 5-propenyl decyloxypentanoic acid (3R,4S)-4,6-bis-(5-acrylenyloxypentanyloxy) in 500 ml DMSO at 50 °C Tetrahydropyran-3-yl ester was stirred with 15.0 ml (0.22 mol) of acrylic acid and 37.0 g (0.27 mol) of potassium carbonate for 24 h. The suspension was diluted with MTBE and washed with water. The aqueous phase was extracted with MTBE and the combined organic phases were washed with saturated sodium chloride. The solution was dried over sodium sulfate and concentrated to dryness. The residue was purified by column was chromatographed (SiO 2 / Al 2 O 3 , dichloromethane: MTBE = 95: 5 and SiO 2, dichloromethane: MTBE = 9: 1), to give a colorless oil propylene 5- Mercaptooxyvaleric acid (3R,4S)-4,6-bis-(5-propenylfluorenylpentenyloxy)tetrahydropyran-3-yl ester (α:β 99:1).

相序:Tg-57 IPhase sequence: Tg-57 I

1 H-NMR(400 MHz,CHCl3):δ=6.41(dd,3H,J=17.2 Hz,J=1.6 Hz,H丙烯酸酯),6.30-6.27(m,1H,H哌喃基),6.12(ddd,3H,J=17.2 Hz,J=10.4 Hz,J=1.6 Hz,H丙烯酸酯),5.83(dd,3H,J=10.4 Hz,J=1.6 Hz,H丙烯酸酯),5.36-5.30(m,1H,H哌喃基),5.24(s(寬),1H,H哌喃基),4.23-4.14(m,6H,3×CH 2 OC(O)),4.01(dd,1H,J=13.0 Hz,J=1.6 Hz,H哌喃基),3.86(dd,1H,J=13.0 Hz,J=2.6 Hz,H哌喃基),2.48-2.40(m,4H,H脂肪族),2.36-2.29(m,2H,H脂肪族),2.28-2.20(m,1H,H哌喃基),1.92(dm,1H,J=13.0 Hz,H哌喃基),1.80-1.67(m,12H,H脂肪族)。 1 H-NMR (400 MHz, CHCl 3 ): δ = 6.41 (dd, 3H, J = 17.2 Hz, J = 1.6 Hz, H acrylate ), 6.30-6.27 (m, 1H, H - pyranyl), 6.12 (ddd, 3H, J = 17.2 Hz, J = 10.4 Hz, J = 1.6 Hz, H acrylate ), 5.83 (dd, 3H, J = 10.4 Hz, J = 1.6 Hz, H acrylate ), 5.36-5.30 ( m,1H,H -Pyloryl ), 5.24 (s (wide), 1H, H - pyranyl), 4.23-4.14 (m, 6H, 3 × CH 2 OC(O)), 4.01 (dd, 1H, J =13.0 Hz, J=1.6 Hz, H -pyridyl ), 3.86 (dd, 1H, J = 13.0 Hz, J = 2.6 Hz, H -pyranyl ), 2.48-2.40 (m, 4H, H aliphatic ), 2.36-2.29 (m, 2H, H aliphatic ), 2.28-2.20 (m, 1H, H -pyranyl ), 1.92 (dm, 1H, J = 13.0 Hz, H -pyranyl ), 1.80-1.67 (m, 12H, H aliphatic ).

實例4:2-甲基丙烯酸(3R,4S,5S)-4,5,6-叁-(2-甲基丙烯醯基氧基)四氫哌喃-3-基酯Example 4: 2-(3R,4S,5S)-4,5,6-indole-(2-methylpropenyloxy)tetrahydropyran-3-yl 2-methacrylate

本發明化合物2-甲基丙烯酸(3R,4S,5S)-4,5,6-叁-(2-甲基丙烯醯基氧基)四氫哌喃-3-基酯係如下文所述合成。The compound of the invention 2-(3R,4S,5S)-4,5,6-indole-(2-methylpropenyloxy)tetrahydropyran-3-yl ester is synthesized as described below .

首先將5.0 g(33.3 mmol) L-(+)-阿拉伯糖與34.0 ml(0.4 mol)甲基丙烯酸及0.2 g(1.6 mmol) DMAP一起引入300 ml THF中。計量加入82.5 g(0.40 mol) DCC於200 ml THF中之溶液,並在室溫下將混合物攪拌20 h。添加25.2 g(0.2 mol)二水草酸,並在1 h後濾出不溶物質。將濾液濃縮至乾燥,並藉由管柱層析(SiO2,二氯甲烷)來純化殘餘物,得到呈端基異構體混合物(α:β=3:1)形式之2-甲基丙烯酸(3R,4S,5S)-4,5,6-叁-(2-甲基丙烯醯基氧基)四氫哌喃-3-基酯。First, 5.0 g (33.3 mmol) of L-(+)-arabinose was introduced into 300 ml of THF together with 34.0 ml (0.4 mol) of methacrylic acid and 0.2 g (1.6 mmol) of DMAP. A solution of 82.5 g (0.40 mol) DCC in 200 ml of THF was added and the mixture was stirred at room temperature for 20 h. 25.2 g (0.2 mol) of oxalic acid was added, and after 1 h, insoluble material was filtered off. The filtrate was concentrated to dryness and by column chromatography (SiO 2, dichloromethane) to give the residue, to give a mixture of isomers as a base end (α: β = 3: 1 ) in the form of methyl methacrylate (3R,4S,5S)-4,5,6-indole-(2-methylpropenyloxy)tetrahydropyran-3-yl ester.

相序:Tg-21 IPhase sequence: Tg-21 I

1H-及13C-NMR譜圖數據與結構一致。 The 1 H- and 13 C-NMR spectrum data were consistent with the structure.

MS(EI):m/e(%)=422(1,M+),337(28,[M-H2C=CH(CH3)-COO]+),41(100)。 MS (EI) : m / e (%) = 422 (1, M + ), 337 (28, [MH 2 C=CH(CH 3 ) -COO] + ), 41 (100).

實例5:2-甲基丙烯酸3-{(3S,4R,5R)-2,3,5-叁-[3-(2-甲基丙烯醯基氧基)丙氧基]四氫哌喃-4-基氧基}丙基酯Example 5: 2-{(3S,4R,5R)-2,3,5-indole-[3-(2-methylpropenyloxy)propoxy]tetrahydropyran- 2-methacrylate 4-yloxy}propyl ester

本發明化合物2-甲基丙烯酸3-{(3S,4R,5R)-2,3,5-叁-[3-(2-甲基丙烯醯基氧基)丙氧基]四氫哌喃-4-基氧基}丙基酯係如下文所述合成。The compound of the present invention 2-{(3S,4R,5R)-2,3,5-indole-[3-(2-methylpropenyloxy)propoxy]tetrahydropyran- The 4-yloxy}propyl ester was synthesized as described below.

5.1 L-(+)-阿拉伯糖之烯丙基化5.1 L-(+)-Allylation of arabinose

將100.0 g(2.50 mol) NaH(存於礦物油中之60%懸浮液)用戊烷洗滌並懸浮於1700 ml DMF中。逐份計量加入62.5 g(0.42 mol) L-(+)-阿拉伯糖,並在超音波浴中將批料攪拌1 h。然後在室溫下將混合物攪拌1 h。以使內部溫度不超過27℃之速率緩慢計量加入220 ml(2.54 mol)烯丙基溴於300 ml DMF中之溶液,同時逆流冷卻。當完成添加後,將混合物攪拌22 h。100.0 g (2.50 mol) of NaH (60% suspension in mineral oil) was washed with pentane and suspended in 1700 ml of DMF. 62.5 g (0.42 mol) of L-(+)-arabinose was metered in and the batch was stirred for 1 h in an ultrasonic bath. The mixture was then stirred at room temperature for 1 h. A solution of 220 ml (2.54 mol) of allyl bromide in 300 ml of DMF was slowly metered at a rate such that the internal temperature did not exceed 27 ° C while cooling in countercurrent. When the addition was completed, the mixture was stirred for 22 h.

向批料中添加乙醇,然後將批料添加至冰水中。將混合物用MTBE萃取數次,並用氯化鈉溶液洗滌合併的有機相。使用硫酸鈉乾燥溶液並濃縮至乾燥。藉由管柱層析(SiO2,CH2Cl2 MTBE)來純化粗產物。Ethanol was added to the batch and the batch was then added to ice water. The mixture was extracted several times with MTBE and the combined organic phases were washed with a sodium chloride solution. The solution was dried over sodium sulfate and concentrated to dryness. The crude product was purified by column chromatography (SiO 2 , CH 2 Cl 2 MTBE).

5.2硼氫化/氧化5.2 Boron Hydrogenation / Oxidation

首先將15.0 g(48.3 mmol)(3S,4R,5R)-2,3,4,5-四烯丙氧基四氫哌喃引入THF中,並添加900 ml(0.45 mol) 9-BBN(存於THF中之0.5 M溶液),並將批料回流5 h。冷卻後,使用水將混合物水解,並添加40 ml 50% NaOH。逐滴添加130 ml(1.49 mol) 30% H2O2並將混合物攪拌19 h。添加50 g碳酸鉀,並輕輕倒出有機相。將溶液用硫酸亞鐵(II)銨溶液處理並使用硫酸鈉乾燥。在去除溶劑後,藉由管柱層析(SiO2,MTBE甲醇)來純化餘下的粗產物,得到無色油狀3-[(3S,4R,5R)-3,4,5-叁-(3-羥基丙氧基)四氫哌喃-2-基氧基]丙-1-醇。First, 15.0 g (48.3 mmol) of (3S,4R,5R)-2,3,4,5-tetraallyloxytetrahydropyran was introduced into THF, and 900 ml (0.45 mol) of 9-BBN was added. The 0.5 M solution in THF) and the batch was refluxed for 5 h. After cooling, the mixture was hydrolyzed with water and 40 ml of 50% NaOH was added. 130 ml (1.49 mol) of 30% H 2 O 2 was added dropwise and the mixture was stirred for 19 h. Add 50 g of potassium carbonate and gently pour out the organic phase. The solution was treated with a solution of ammonium ferrous sulfate (II) and dried over sodium sulfate. After removal of the solvent by column chromatography (SiO 2, MTBE methanol) to give the remaining crude product was obtained as a colorless oil 3 - [(3S, 4R, 5R) -3,4,5- three - ( 3-hydroxypropoxy)tetrahydropyran-2-yloxy]propan-1-ol.

5.3使用甲基丙烯酸進行酯化5.3 Esterification using methacrylic acid

首先將8.0 g(20.9 mmol) 3-[(3S,4R,5R)-3,4,5-叁-(3-羥基丙氧基)四氫哌喃-2-基氧基]丙-1-醇與21.3 ml(0.25 mol)甲基丙烯酸及0.2 g(1.6 mmol) DMAP一起引入200 ml THF中。計量加入50.0 g(0.24 mol) DCC於100 ml THF中之溶液,並在室溫下將混合物攪拌22 h。添加二水草酸,並在1 h後濾出不溶物質。將濾液濃縮至乾燥,並藉由層析來純化殘餘物,得到呈端基異構體混合物(α:β=95:5)形式之2-甲基丙烯酸3-{(3S,4R,5R)-2,3,5-叁-[3-(2-甲基丙烯醯基氧基)丙氧基]四氫哌喃-4-基氧基}丙基酯。First, 8.0 g (20.9 mmol) of 3-[(3S,4R,5R)-3,4,5-indole-(3-hydroxypropoxy)tetrahydropyran-2-yloxy]propan-1- The alcohol was introduced into 200 ml of THF along with 21.3 ml (0.25 mol) of methacrylic acid and 0.2 g (1.6 mmol) of DMAP. A solution of 50.0 g (0.24 mol) DCC in 100 ml THF was added and the mixture was stirred at room temperature for 22 h. Dioxalic acid was added and the insoluble material was filtered off after 1 h. The filtrate was concentrated to dryness, and the residue was purified by chromatography to afford 2-[(3S,4R,5R) 2- methacrylic acid as a mixture of anomers (α:β=95:5) -2,3,5-indole-[3-(2-methylpropenyloxy)propoxy]tetrahydropyran-4-yloxy}propyl ester.

1H-及13C-NMR譜圖數據與結構一致。 The 1 H- and 13 C-NMR spectrum data were consistent with the structure.

MS(EI):m/e(%)=654(1,M+),325(5),127(100)。 MS (EI) : m/e (%) = 654 (1, M + ), 325 (5), 127 (100).

實例6-9:Example 6-9:

實例化合物6-9與實例1類似係自相應糖及與溴戊酸及甲基丙烯酸之反應獲得。在每一情形下,譜圖數據(NMR,MS)均與結構一致。Example Compounds 6-9 were obtained analogously to Example 1 from the corresponding sugars and reacted with bromopentanoic acid and methacrylic acid. In each case, the spectral data (NMR, MS) were consistent with the structure.

使用實例Use case

以下縮寫詞用於闡述液晶基本混合物(主體)之組份:The following abbreviations are used to describe the components of the liquid crystal basic mixture (main body):

使用下列單體:Use the following monomers:

RM220具有相序C 82.5 N 97 I。RM220 has a phase sequence C 82.5 N 97 I.

RM257具有相序C 66 N 127 I。RM257 has a phase sequence of C 66 N 127 I.

使用下列添加劑:(DP:對掌性摻雜劑,IN:聚合起始劑)The following additives were used: (DP: palmitic dopant, IN: polymerization initiator)

聚合說明Aggregation description

在樣品聚合前,在厚度為約10微米且面積為2×2.5 cm之測試槽中測定介質之相性質。在75℃之溫度下該槽因毛細作用而充滿。該量測係在具有熱台之偏光顯微鏡下實施,溫度程式為1℃/min。The phase properties of the medium were determined in a test cell having a thickness of about 10 microns and an area of 2 x 2.5 cm prior to sample polymerization. The tank is filled with capillary action at a temperature of 75 °C. The measurement was carried out under a polarizing microscope with a hot stage at a temperature of 1 ° C/min.

介質之聚合係藉由用有效功率為約1.5 mW/cm2之UV燈(Hnle,Bluepoint 2.1,365 nm干涉濾光片)輻照180秒來實施。聚合係直接在光電測試槽中實施。聚合起初係在使介質處於藍相I(BP-I)之溫度下實施。聚合係在複數個子步驟中實施,該等子步驟逐漸達成完全聚合。在聚合期間藍相之溫度範圍通常發生改變。因此,在各個子步驟之間,可改變溫度以使介質仍處於藍相。在實踐中,此可藉由在每次輻照作業後約5 s或更久在偏光顯微鏡下觀測樣品來實施。若樣品變暗,則指示轉變為各向同性相。相應地可降低下一子步驟之溫度。在所指出輻照功率下達成最大穩定之整個輻照時間通常為180 s。可根據最佳輻照/溫度程式實施其他聚合。另一選擇為,聚合亦可在單次輻照步驟中實施,具體而言若甚至在聚合前就已存在寬的藍相。The polymerization of the medium is carried out by using a UV lamp (H) having an effective power of about 1.5 mW/cm 2 . Nle, Bluepoint 2.1, 365 nm interference filter) was irradiated for 180 seconds. The polymerization is carried out directly in the photoelectric test cell. The polymerization is initially carried out at a temperature such that the medium is at a blue phase I (BP-I). The polymerization is carried out in a plurality of sub-steps which gradually reach a complete polymerization. The temperature range of the blue phase typically changes during the polymerization. Thus, between each substep, the temperature can be varied to keep the medium in the blue phase. In practice, this can be carried out by observing the sample under a polarizing microscope about 5 s or more after each irradiation operation. If the sample becomes dark, the indication is converted to an isotropic phase. Accordingly, the temperature of the next substep can be lowered. The overall irradiation time to achieve maximum stability at the indicated irradiation power is typically 180 s. Other polymerizations can be performed according to the optimal irradiation/temperature program. Alternatively, the polymerization can also be carried out in a single irradiation step, in particular if a broad blue phase is present even before polymerization.

光電表徵Photoelectric characterization

在使藍相經歷上述聚合並穩定後,測定藍相之相寬度。隨後在不同溫度下實施光電表徵,該溫度可處於此範圍內且視需要亦可處於此範圍外。After the blue phase was subjected to the above polymerization and stabilized, the phase width of the blue phase was measured. Photoelectric characterization is then carried out at different temperatures, which may be in this range and may also be outside this range as desired.

所用測試槽在一側槽表面上安裝有叉指電極。槽間隙、電極間距及電極寬度通常各自為10微米。此均勻尺寸下文稱為間隙寬度。電極覆蓋之面積為約0.4 cm2。測試槽不具有配向層。為進行光電表徵,將槽置於交叉偏振濾光片之間,電極縱向與偏振濾光片軸線呈45°角。使用DMS301(Autronic-Melchers)相對於槽平面以恰當角度實施量測,或借助高敏感照相機在偏光顯微鏡上實施量測。在無電壓狀態,所述配置產生基本上為黑色的圖像(定義為透射率為0%)。The test slot used has an interdigital electrode mounted on the surface of one of the grooves. The slot gap, electrode spacing and electrode width are typically each 10 microns. This uniform size is hereinafter referred to as the gap width. The area covered by the electrodes is about 0.4 cm 2 . The test slot does not have an alignment layer. For photoelectron characterization, the grooves were placed between crossed polarizing filters with the electrodes longitudinally at an angle of 45 to the axis of the polarizing filter. Measurements were performed at appropriate angles with respect to the plane of the grooves using DMS301 (Autronic-Melchers) or on polarized microscopes with high sensitivity cameras. In the no voltage state, the configuration produces a substantially black image (defined as a transmission of 0%).

首先,在測試槽上量測特性操作電壓且然後量測響應時間。操作電壓係以具有交替符號(頻率為100 Hz)及可變振幅之矩形電壓形式施加至槽電極,如下文所述。First, the characteristic operating voltage is measured on the test slot and then the response time is measured. The operating voltage is applied to the slot electrode in the form of a rectangular voltage having alternating signs (frequency of 100 Hz) and variable amplitude, as described below.

將無電壓狀態之透射率設定為0%。在增加操作電壓的同時量測透射率。以達到約100%強度之最大值定義操作電壓V100之特性品質。同樣,在10%之最大透射率下測定特性電壓V10。此等值係在處於藍相範圍內之不同溫度下測定。The transmittance in the no-voltage state was set to 0%. The transmittance is measured while increasing the operating voltage. The characteristic quality of the operating voltage V 100 is defined by a maximum of about 100% intensity. Also, the characteristic voltage V 10 was measured at a maximum transmittance of 10%. These values are determined at different temperatures in the blue phase range.

在處於藍相溫度範圍下端時,觀測到相對較高的特性操作電壓V100。在處於溫度範圍上端(接近澄清點)時,V100之值大大增加。在最小操作電壓區域中,V100通常僅隨溫度緩慢增加。此溫度範圍稱為可用平坦溫度範圍(flat temperature range)(FR),其由T1及T2界定。「平坦範圍」(FR)之寬度係(T2-T1)且稱為平坦範圍寬度(WFR)。T1及T2之精確值係藉由V100/溫度圖中平坦曲線部分FR之正切與毗鄰陡峭曲線部分之正切的交叉點來確定。At the lower end of the blue phase temperature range, a relatively high characteristic operating voltage V 100 is observed. At the upper end of the temperature range (close to the clearing point), the value of V 100 is greatly increased. In the region of minimum operating voltage, V 100 typically only slowly increases with temperature. This temperature range is referred to as the available flat temperature range (FR), which is defined by T 1 and T 2 . The width of the "flat range" (FR) is (T 2 -T 1 ) and is called the flat range width (WFR). The exact values of T 1 and T 2 are determined by the intersection of the tangent of the flat curve portion FR in the V 100 /temperature map and the tangent of the adjacent steep curve portion.

在量測之第二部分中,在開關期間測定響應時間(τonoff)。響應時間τon定義為在所選溫度下以V100之位準施加電壓後達到90%強度所耗費的時間。響應時間τoff定義為在電壓減小至0 V後自V100下之最大強度開始下降90%所耗費的時間。響應時間亦係在處於藍相範圍之不同溫度下測定。In the second part of the measurement, the response time (τ on , τ off ) is determined during the switching. The response time τ on is defined as the time it takes to reach 90% intensity after applying a voltage at the V 100 level at the selected temperature. The response time τ off is defined as the time it takes for the maximum intensity from V 100 to begin to fall by 90% after the voltage is reduced to 0 V. The response time is also measured at different temperatures in the blue phase range.

作為進一步表徵,在處於FR範圍內之溫度下針對在0 V與V100之間連續變化之操作電壓量測透射率。比較增加及減小操作電壓之曲線可獲得滯後。在0.5‧V100下透射率間之差及在50%透射率下電壓間之差係(例如)特性滯後值且分別稱為ΔT50及ΔV50As a further characterization, the transmittance is measured for operating voltages that vary continuously between 0 V and V 100 at temperatures in the FR range. The hysteresis can be obtained by comparing the curves of increasing and decreasing the operating voltage. The difference between the transmittances at 0.5‧V 100 and the difference between the voltages at 50% transmittance are, for example, characteristic hysteresis values and are referred to as ΔT 50 and ΔV 50 , respectively .

應用實例M1(用於比較)、M2、M3(用於比較)、M4Application example M1 (for comparison), M2, M3 (for comparison), M4

下列可聚性介質具有下列組成:The following polymerizable media have the following composition:

在聚合前按照所闡述對該等介質進行表徵。然後藉由在藍相中實施單次輻照(180 s)使RM組份聚合,並再次對所得介質進行表徵。The media are characterized as described prior to polymerization. The RM component was then polymerized by performing a single irradiation (180 s) in the blue phase and the resulting medium was characterized again.

與介質M1及M3(不含RM-1)相比,已與RM-1聚合之本發明介質M2及M4展示操作電壓(V10,V100)及滯後(△V50)顯著減小。混合物M3及M4因對掌性摻雜劑之比例增加而不同於混合物M1及M2,此意味著與M1/M2相反,M3/M4形成不可見藍相(波長偏移至UV區域)。實例M3及M4顯示滯後及操作電壓因針對不可見藍相之闡釋性內容而有所減小。Compared to the media M1 and M3 (excluding RM-1), the inventive media M2 and M4 which have been polymerized with RM-1 exhibit a significant reduction in operating voltage (V 10 , V 100 ) and hysteresis (ΔV 50 ). Mixtures M3 and M4 differ from mixtures M1 and M2 by an increase in the proportion of palmitic dopants, which means that in contrast to M1/M2, M3/M4 forms an invisible blue phase (wavelength shifted to the UV region). Examples M3 and M4 show that hysteresis and operating voltage are reduced due to the interpretive content for the invisible blue phase.

Claims (11)

一種式IA化合物 其中R1及R2表示a)在每一情形下,彼此獨立地為具有1個至15個C原子之鹵代或未經取代之烷基,另外,其中此等基團中之一或多個CH2基團可以O原子彼此不直接連接之方式各自彼此獨立地由-C≡C-、-CH=CH-、-(CO)O-、-O(CO)-、-(CO)-或-O-替代,b)基團-Sp-P,或c)F、Cl、H、Br、CN、SCN、NCS或SF5,A2 表示m 表示1、2或3,P 在每一情形下彼此獨立地選自丙烯酸酯基及甲基丙烯酸酯基,Sp 在每一情形下彼此獨立地表示單鍵或選自式Sp'-X,以使基團P-Sp-符合式P-Sp'-X-,其中 Sp' 表示具有1個至24個C原子之伸烷基,其視情況經F、Cl、Br、I或CN單-或多取代,且另外,其中一或多個不毗鄰CH2基團以O及/或S原子彼此不直接連接之方式各自彼此獨立地經-O-、-S-、-NH-、-NR0-、-SiR00R000-、-CO-、-COO-、-OCO-、-OCO-O-、-S-CO-、-CO-S-、-NR00-CO-O-、-O-CO-NR00-、-NR00-CO-NR00-、-CH=CH-或-C≡C-替代,X 表示-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR00-、-NR00-CO-、-NR00-CO-NR00-、-OCH2-、-CH2O-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CF2CH2-、-CH2CF2-、-CF2CF2-、-CH=N-、-N=CH-、-N=N-、-CH=CR0-、-CY2=CY3-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-或單鍵,R00及R000各自彼此獨立地表示H或具有1個至12個C原子之烷基,Y2及Y3各自彼此獨立地表示H、F、Cl或CN,且-Sp-P 另外亦一起表示基團R1, 其中可聚性基團P之數量為一或多個,其中該等式IA化合物係選自式IA-1至IA-32化合物: 其中,R1'至R5'採用如上文中針對R1所指出之含義,X1至X5係如上文中針對X所定義,Sp1至Sp5係如上文中針對Sp'所定義者,及P1至P5係如上文中針對P所定義者,且其中不包括式ABCD之化合物 其中a+b+c+d表示>10的自然數 a compound of formula IA Wherein R 1 and R 2 represent a) in each case, independently of each other, a halogenated or unsubstituted alkyl group having from 1 to 15 C atoms, in addition, one or more of such groups The CH 2 groups may be independently of each other by -C≡C-, -CH=CH-, -(CO)O-, -O(CO)-, -(CO)- in such a manner that the O atoms are not directly connected to each other. Or -O-substitution, b) group-Sp-P, or c) F, Cl, H, Br, CN, SCN, NCS or SF 5 , A 2 represents or m represents 1, 2 or 3, and P is, in each case, independently of one another selected from the group consisting of acrylate groups and methacrylate groups, and Sp in each case independently represents a single bond or is selected from the group of Sp'-X, In order for the group P-Sp- to conform to the formula P-Sp'-X-, wherein Sp' represents an alkylene group having from 1 to 24 C atoms, which is optionally via F, Cl, Br, I or CN - Or polysubstituted, and additionally, one or more of the non-adjacent CH 2 groups are each independently -O-, -S-, -NH-, -NR in such a manner that O and/or S atoms are not directly connected to each other 0 -, -SiR 00 R 000 -, -CO-, -COO-, -OCO-, -OCO-O-, -S-CO-, -CO-S-, -NR 00 -CO-O-, - O-CO-NR 00 -, -NR 00 -CO-NR 00 -, -CH=CH- or -C≡C- instead, X means -O-, -S-, -CO-, -COO-, - OCO-, -O-COO-, -CO-NR 00 -, -NR 00 -CO-, -NR 00 -CO-NR 00 -, -OCH 2 -, -CH 2 O-, -SCH 2 -, - CH 2 S-, -CF 2 O-, -OCF 2 -, -CF 2 S-, -SCF 2 -, -CF 2 CH 2 -, -CH 2 CF 2 -, -CF 2 CF 2 -, -CH =N-, -N=CH-, -N=N-, -CH=CR 0 -, -CY 2 =CY 3 -, -C≡C-, -CH=CH-COO-, -OCO-CH= CH- or a single bond, R 00 and R 000 are each independently of one another denote H or with 1 to 12 C atoms in the alkyl group, Y 2 and Y 3 are each independently H, F, Cl or CN, and also addition -Sp-P together represent the group R 1, wherein the polymerizable group P The amount is one or more, wherein the compound of the formula IA is selected from the group consisting of the compounds of the formulae IA-1 to IA-32: Wherein R 1 ' to R 5 ' are as defined above for R 1 , X 1 to X 5 are as defined above for X, and Sp 1 to Sp 5 are as defined above for Sp′, and P 1 to P 5 are as defined above for P, and do not include compounds of formulas A , B , C and D Where a+b+c+d represents a natural number >10 如請求項1之化合物,其特徵在於環A2及其取代基之數量及位置對應於選自下列糖之糖:核糖、脫氧核糖、阿拉伯糖、木糖、來蘇糖、核酮糖、木酮糖、葡萄糖、阿洛糖、阿卓糖、甘露糖、古洛糖、艾杜糖、半乳糖、塔羅糖、果糖、岩藻糖或鼠李糖。 The compound of claim 1, characterized in that the number and position of the ring A 2 and its substituent correspond to a sugar selected from the group consisting of ribose, deoxyribose, arabinose, xylose, lyxose, ribulose, wood Keto, glucose, allose, altrose, mannose, gulose, idose, galactose, talose, fructose, fucose or rhamnose. 如請求項1或2之化合物,其特徵在於R1及/或R2表示P-Sp-基團、H、具有1-10個C原子之烷氧基或烷氧基甲基。 A compound according to claim 1 or 2, characterized in that R 1 and/or R 2 represents a P-Sp- group, H, an alkoxy group having 1 to 10 C atoms or an alkoxymethyl group. 如請求項1或2之化合物,其特徵在於可聚性基團之數量為2、3、4或5。 A compound according to claim 1 or 2, characterized in that the number of polymerizable groups is 2, 3, 4 or 5. 一種製備如請求項1至4中任一項之式IA化合物之方法,該方法係藉由單糖之衍生來實施。 A process for the preparation of a compound of formula IA according to any one of claims 1 to 4 which is carried out by the derivatization of a monosaccharide. 一種液晶介質,其特徵在於其包含一或多種式IA化合物 其中R1及R2 表示a)在每一情形下,彼此獨立地為具有1個至15個C原子之鹵代或未經取代之烷基,另外,其中此等基團中之一或多個CH2基團可以O原子彼此不直接連接之方式各自彼此獨立地經-C≡C-、-CH=CH-、-(CO)O-、-O(CO)-、-(CO)-或-O-替代,b)基團-Sp-P,c)F、Cl、H、Br、CN、SCN、NCS或SF5,A2 表示m 表示1、2或3,P 在每一情形下彼此獨立地選自丙烯酸酯基及甲基丙烯酸酯基,Sp 在每一情形下彼此獨立地表示單鍵或選自式Sp'-X,以使基團P-Sp-符合式P-Sp'-X-,其中Sp' 表示具有1個至24個C原子之伸烷基,其視情況經F、Cl、Br、I或CN單-或多取代,且另外,其中一或多個不毗鄰CH2基團以O及/或S原子彼此不直接連接之方式各自彼此獨立地經-O-、-S-、-NH-、-NR0-、-SiR00R000-、-CO-、-COO-、-OCO-、-OCO-O-、-S-CO-、- CO-S-、-NR00-CO-O-、-O-CO-NR00-、-NR00-CO-NR00-、-CH=CH-或-C≡C-替代,X 表示-O-、-S-、-CO-、-COO-、-OCO-、-O-COO-、-CO-NR00-、-NR00-CO-、-NR00-CO-NR00-、-OCH2-、-CH2O-、-SCH2-、-CH2S-、-CF2O-、-OCF2-、-CF2S-、-SCF2-、-CF2CH2-、-CH2CF2-、-CF2CF2-、-CH=N-、-N=CH-、-N=N-、-CH=CR0-、-CY2=CY3-、-C≡C-、-CH=CH-COO-、-OCO-CH=CH-或單鍵,R00及R000各自彼此獨立地表示H或具有1個至12個C原子之烷基,Y2及Y3各自彼此獨立地表示H、F、Cl或CN,且-Sp-P 另外亦一起表示基團R1,其中該等式IA化合物係選自式IA-1至IA-32化合物: 其中,R1'至R5'採用如上文中針對R1所指出之含義,X1至X5係如上文中針對X所定義,Sp1至Sp5係如上文中針對Sp'所定義者,及P1至P5係如上文中針對P所定義者;或包含一或多種該式IA化合物之聚合物。 A liquid crystal medium characterized by comprising one or more compounds of the formula IA Wherein R 1 and R 2 represent a) in each case, independently of each other, a halogenated or unsubstituted alkyl group having from 1 to 15 C atoms, in addition, one or more of such groups The CH 2 groups may each independently pass through -C≡C-, -CH=CH-, -(CO)O-, -O(CO)-, -(CO)- in such a manner that the O atoms are not directly connected to each other. Or -O-substitution, b) group -Sp-P, c) F, Cl, H, Br, CN, SCN, NCS or SF 5 , A 2 represents or m represents 1, 2 or 3, and P is, in each case, independently of one another selected from the group consisting of acrylate groups and methacrylate groups, and Sp in each case independently represents a single bond or is selected from the group of Sp'-X, In order for the group P-Sp- to conform to the formula P-Sp'-X-, wherein Sp' represents an alkylene group having from 1 to 24 C atoms, which is optionally via F, Cl, Br, I or CN - Or polysubstituted, and additionally, one or more of the non-adjacent CH 2 groups are each independently -O-, -S-, -NH-, -NR in such a manner that O and/or S atoms are not directly connected to each other 0 -, -SiR 00 R 000 -, -CO-, -COO-, -OCO-, -OCO-O-, -S-CO-, -CO-S-, -NR 00 -CO-O-,- O-CO-NR 00 -, -NR 00 -CO-NR 00 -, -CH=CH- or -C≡C- instead, X means -O-, -S-, -CO-, -COO-, - OCO-, -O-COO-, -CO-NR 00 -, -NR 00 -CO-, -NR 00 -CO-NR 00 -, -OCH 2 -, -CH 2 O-, -SCH 2 -, - CH 2 S-, -CF 2 O-, -OCF 2 -, -CF 2 S-, -SCF 2 -, -CF 2 CH 2 -, -CH 2 CF 2 -, -CF 2 CF 2 -, -CH =N-, -N=CH-, -N=N-, -CH=CR 0 -, -CY 2 =CY 3 -, -C≡C-, -CH=CH-COO-, -OCO-CH= CH- or a single bond, R 00 and R 000 each independently represent H or An alkyl group having 1 to 12 C atoms, each of Y 2 and Y 3 independently representing H, F, Cl or CN, and -Sp-P additionally together represent a group R 1 wherein the compound of the formula IA Is selected from the group consisting of compounds of formula IA-1 to IA-32: Wherein R 1 ' to R 5 ' are as defined above for R 1 , X 1 to X 5 are as defined above for X, and Sp 1 to Sp 5 are as defined above for Sp′, and P 1 to P 5 are as defined above for P; or a polymer comprising one or more compounds of the formula IA. 如請求項6之液晶介質,其特徵在於在藉由聚合來穩定 藍相後,其至少在20℃至25℃範圍內具有該藍相。 The liquid crystal medium of claim 6, characterized in that it is stabilized by polymerization After the blue phase, it has the blue phase at least in the range of 20 ° C to 25 ° C. 一種製造包含經液晶聚合物穩定之介質之光電裝置之方法,其特徵在於使包含一或多種如請求項6之式IA化合物之液晶介質發生聚合。 A method of making a photovoltaic device comprising a medium stabilized by a liquid crystal polymer, characterized in that a liquid crystal medium comprising one or more compounds of the formula IA of claim 6 is polymerized. 一種利用一或多種如請求項6所載之式IA化合物作為液晶介質中之組份或聚合物組份之用途。 A use of one or more compounds of the formula IA as set forth in claim 6 as a component or polymer component in a liquid crystal medium. 一種如請求項6或7之液晶介質之用途,其係用於光電用途。 A use of the liquid crystal medium of claim 6 or 7 for photovoltaic applications. 一種光電液晶顯示器,其包含如請求項6或7之液晶介質。 An optoelectronic liquid crystal display comprising the liquid crystal medium of claim 6 or 7.
TW099131768A 2009-09-18 2010-09-17 Polymerisable compounds and liquid-crystal media TWI629282B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102009041806 2009-09-18
??102009041806.7 2009-09-18

Publications (2)

Publication Number Publication Date
TW201127847A TW201127847A (en) 2011-08-16
TWI629282B true TWI629282B (en) 2018-07-11

Family

ID=43127825

Family Applications (1)

Application Number Title Priority Date Filing Date
TW099131768A TWI629282B (en) 2009-09-18 2010-09-17 Polymerisable compounds and liquid-crystal media

Country Status (3)

Country Link
DE (1) DE102010034968B4 (en)
TW (1) TWI629282B (en)
WO (1) WO2011032630A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112852445A (en) * 2021-01-08 2021-05-28 深圳市华星光电半导体显示技术有限公司 Liquid crystal composition, liquid crystal display panel and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744057A (en) * 1995-06-09 1998-04-28 Basf Aktiengesellshaft Polymerizable, chiral compounds, and use thereof
WO2008061606A1 (en) * 2006-11-24 2008-05-29 Merck Patent Gmbh Cyclohexylene reactive mesogens and their applications

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4560534A (en) * 1983-11-02 1985-12-24 Miles Laboratories, Inc. Polymer catalyst transducers
US5116961A (en) 1990-12-07 1992-05-26 Hawaiian Sugar Planters' Association 1',6,6'-trimethacryloyl-2,3,3',4,4'-penta-O-methylsucrose
US5248747A (en) 1990-12-07 1993-09-28 Hawaiian Sugar Planters' Association Polymers having enhanced crosslinking efficiencies, and methods for their preparation using 1',6,6'-trimethacryloyl-2,3,3',4,4'-penta-O-methylsucrose as a crosslinking agent
US5302676A (en) 1990-12-07 1994-04-12 Hawaiian Sugar Planters' Association Polymers having enhanced crosslinking efficiencies, and methods for their preparation using 1',6,6'-trimethacryloyl-2,3,3',4,4'-penta-O-methyl sucrose as a crosslinking agent
WO1994014828A2 (en) 1992-12-23 1994-07-07 Arthur D. Little, Inc. Ion-conductive polymer and electrolyte additives
JPH1036847A (en) 1996-07-25 1998-02-10 Seiko Epson Corp Liquid crystal display device and process for preparing the same
US7060200B1 (en) 1999-09-03 2006-06-13 Merck Patent Gmbh Multireactive polymerizable mesogenic compounds
JP2002023199A (en) 2000-07-07 2002-01-23 Fujitsu Ltd Liquid crystal display device and manufacturing method therefor
JP4175826B2 (en) 2002-04-16 2008-11-05 シャープ株式会社 Liquid crystal display
DE50306559D1 (en) 2002-07-06 2007-04-05 Merck Patent Gmbh Liquid crystalline medium
AU2003286165A1 (en) 2002-11-15 2004-06-15 Merck Patent Gmbh Electrooptical light modulating element, electrooptical display and modulating medium
JP2004294605A (en) 2003-03-26 2004-10-21 Fujitsu Display Technologies Corp Liquid crystal panel
WO2005080529A1 (en) 2004-02-20 2005-09-01 Asahi Glass Company, Limited Liquid crystal material for optical device and optical modulation device
JP2005283632A (en) 2004-03-26 2005-10-13 Fuji Photo Film Co Ltd Polymerizable composition and negative image recording material
JP4387276B2 (en) 2004-09-24 2009-12-16 シャープ株式会社 Liquid crystal display
US7527746B2 (en) 2005-01-28 2009-05-05 Chisso Corporation Liquid crystal polyfunctional acrylate derivative and polymer thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744057A (en) * 1995-06-09 1998-04-28 Basf Aktiengesellshaft Polymerizable, chiral compounds, and use thereof
WO2008061606A1 (en) * 2006-11-24 2008-05-29 Merck Patent Gmbh Cyclohexylene reactive mesogens and their applications

Also Published As

Publication number Publication date
DE102010034968A1 (en) 2011-03-31
DE102010034968B4 (en) 2019-10-31
TW201127847A (en) 2011-08-16
WO2011032630A1 (en) 2011-03-24

Similar Documents

Publication Publication Date Title
JP5908209B2 (en) LCD display
KR101498750B1 (en) Liquid crystal display
KR101646804B1 (en) Liquid crystal display
KR101709807B1 (en) Liquid crystal display
KR101898748B1 (en) Polymerisable compounds and the use thereof in liquid-crystal displays
KR20120099421A (en) Polymerizable compounds and their use in liquid-crystal displays
TWI595078B (en) Polymerisable compounds and the use thereof in liquid-crystal displays
JP5844357B2 (en) Polymerizable compounds and their use in liquid crystal displays
TWI532714B (en) Polymerisable compounds and the use thereof in liquid-crystal displays
TW201943840A (en) Liquid crystal mixture and liquid crystal display
TWI629282B (en) Polymerisable compounds and liquid-crystal media
TW202104553A (en) Polymerisable compounds and the use thereof in liquid-crystal displays
TWI552992B (en) Polymerisable compounds and liquid-crystal media

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees